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    ABSTRACT-I 
Background: Heterogeneous cell populations have previously been described as noisy. However, 
recent studies have demonstrated that heterogeneity can be biologically significant. We present 
here an approach for rapid and complete identification of heterogeneous cell populations from 
high-throughput flow cytometry data.  We have developed a novel measure Slope Differentiation 
Identification (SDI) using flow cytometry-based protein expression, quantifying the rate of change 
in protein expression between two conditions (exponential and stationary phase) of yeast cells, as a 
function of cell size or cell granularity.    
Results:  SDI had superior Gene Ontology enrichment when compared with other approaches such 
as k-means clustering and an approach based on the bi-modality of the fluorescence intensity 
distribution. Cell populations were also validated using gradient-separation followed by 
microscopy, where proteins with high SDI measure showed significant levels of differentiation 
between high and low density cells.    
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Conclusion: Overall, our approach has identified novel protein expression patterns that differentiate 
quiescent and non-quiescent cell populations.    
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ABSTRACT-II 
 
Background:  With the advent of genomics, there has been a rapid increase in the use of two and one-
color microarrays, used to measure mRNA abundance for the entire genome.  Variability in microarray 
analysis undermines its utility in identifying the entire subset of differentially expressed mRNAs.  Recent 
microarray studies have shown that, although it is assumed that variances are constant for every 
hybridized spot within a microarray, variances may differ for each biological sample analyzed (Ritchie, 
Diyagama et al. 2006).   Another common assumption is that log-intensity values for any given gene 
have a Normal distribution.  For many datasets, both assumptions have been shown to be incorrect, 
resulting in distortions in the significance when testing for differential expression of each gene (Bar-
Even, Paulsson et al. 2006; Wentzell, Karakach et al. 2006).   
Approach: To overcome the limitations of existing approaches in identifying significant, differentially 
expressed genes, we have developed a novel unsupervised statistical approach called Calibration 
Regression Analysis of Microarrays (CRAM) that uses a combination of empirical Bayes and regression 
calibration.  The main novelty of our approach is the modeling of gene expression variances as a function 
of the log-intensity within each sample.  Another version was later developed CRAM-GS in which the 
association between genes is captured using an adjusted gene correlation measure. 
Results:  CRAM was compared to four existing approaches for identifying differentially expressed 
genes.  Performance was based on the ability to identify co-regulated genes in the same Gene Ontology 
process.  CRAM exhibited a marginal improvement in GO process enrichment compared with the other 
approaches.  To the original datasets, three more were included in which the later version CRAM-GS, 
showed a significant improvement compared to CRAM, suggesting a major additional benefit of 
incorporating gene correlations into the model.  All versions of CRAM were two orders of magnitude 
x 
 
faster than the existing approaches. Overall, CRAM provides an adaptive, computationally efficient 
approach for accurate identification of differentially expressed genes. 
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Chapter 1 – Introduction 
1.1 Functional Genomics 
Functional genomics, the study of levels of cellular organization in a whole-
genome context, was developed as an outgrowth of genomic sequencing projects.  
Functional genomics aims to describe gene and protein functions and their interactions, 
extending basic concepts of genomics and proteomics by describing dynamic aspects 
such as transcription, translation and protein-protein interactions.  In summary, functional 
genomics can be viewed as a dynamic evolution of the static aspects of genomic 
information such as DNA sequences.  After the completion of the Human Genome 
Project in 2001,  an immediate challenge using functional genomics, was to identify the 
relations between genes, proteins and the environment that were responsible for the 
evolution and functioning of dynamic living systems (Sebastiani, Gussoni et al. 2003).   
Our mail goal is to apply quantitative methods in functional genomics in order to better 
understand the biological processes involved in many diseases such as cancer, aging and 
stem cells.  For this purpose, we developed novel high-throughput statistical methods 
applied to recent technologies, to study stationary phase cultures in yeast.  However, our 
methods can also be applicable to other types of experiments. 
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1.2 New technologies 
Recent advances in technologies, such as microarrays (Fig. 1) and flow cytometry      
(Fig. 2), permit researchers to make inferences on dynamic living systems, by observing 
relations between thousands of mRNAs or proteins in an organism, under the same 
experimental conditions.  Massive amounts of data resulting from these technological 
advances soon became available, giving rise to another challenge with the analysis of all 
this new information.   To handle the size and complexity of all the new biological data, 
sophisticated and computationally intensive data analysis methods had to be developed. 
 
1.2.1 Microarrays 
Since the introduction of microarray technology in the 1990’s, microarray 
experiments have been used in molecular biology and in medicine to quantify the 
abundance of all mRNA in an organism (Fig. 1), and to attempt to infer the relationship 
between mRNA abundance, biological development, disease and physiology (Eisen and 
Brown 1999).   In the analysis after compiling all the networks and information in a 
microarray dataset, lists of candidate genes are generated and are often referred to as 
differentially expressed genes.   The overall concept involving lists of candidate genes is 
the assumption that these genes are interrelated and are part of the same metabolic 
pathway.   
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Figure 1 - (http://www.dnamicroarray.net/)  In spotted microarrays the probes are 
oligonucleotides, cDNA, or small fragments of PCR products that correspond to mRNAs. 
Each probe contains a different, characteristic sequence that is specific to a different 
group of genes under study. These probes are then spotted onto glass substrate to form an 
array. One common approach uses an array of fine needles controlled by a robotic arm 
that is dipped into wells containing different DNA probes. Each needle then deposits its 
probe onto designated locations on the array surface. The probes are then ready to 
hybridize with complementary cDNA and cRNA targets derived from experimental or 
clinical samples.  
 
One of the challenges in the analysis of microarray data is to integrate and 
compare the differential gene lists from multiple experiments for common or unique 
underlying biological themes (Yi, Mudunuri et al. 2009).   One way to approach this 
challenge is by selecting common genes from these gene lists and then subjecting these 
genes to enrichment analysis in order to reveal the underlying biology.  However, this 
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approach is highly restricted by the limited gene overlaps shared by datasets from 
multiple experiments, which could be originated by the complexity of the biological 
system itself.   On the other hand, small gene overlaps can be the result of sub-optimal 
measures of differential expression, and gene list overlaps can be largely improved by the 
use of more accurate statistical measures (Shi, Perkins et al. 2008).   In the current work, 
we introduce a novel statistical method, Calibration Regression Analysis of Microarrays 
(CRAM) and some of its variations, in which microarrays are used to optimally model 
gene expression in yeast (Saccharomyces cerevisiae).  
 
1.2.2 Flow cytometry 
Flow cytometry (Fig. 2) is a well established technique in cell biology, first 
developed in the 1970’s for quantifying fluorescence of single cells and other 
morphological characteristics, such as size and granularity (Watson 1987).  Since its 
introduction, the flow cytometer has rapidly become an essential instrument for 
biological sciences.  In the cytometer, cells are suspended and aspirated into a flow 
chamber passing one at a time through a focused laser beam (Fig. 2).  When the light 
strikes the cell, it is either scattered or absorbed, resulting in quantitative information for 
every cell.  Since large numbers of cells are analyzed in a short period of time 
(>30,000/sec), a large amount of valid information about cell populations is quickly 
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obtained (Riley 2002).   
 
Figure 2 -
(http://www.bioteach.ubc.ca/MolecularBiology/FlowCytometry/flowcytometry.gif) 
Detection of fluorescent measurements of cells passing through a laser beam, where 
many thousands of cells can be measured, counted and sorted.  
 
 
Flow data has multiple dimensions leading to far greater computational analysis 
and high information content.  These large numbers of multi-dimensional data points are 
from a statistical point of view, one of flow cytometry’s major strengths (Krutzik, Irish et 
al. 2004).  In the current work, a novel high-throughput flow cytometry method called 
Slope Differentiation Identification (SDI) is developed, based on protein expression 
measurements in yeast.  Similar to microarrays, the primary goal is to generate 
statistically robust lists of candidate genes that reveal distinct populations of cells in 
heterogeneous cultures. 
 
 
 
 
6 
 
1.2.3 Other Technologies 
A more recent technology called RNA-Seq, also called "Whole Transcriptome 
Shotgun Sequencing" (WTTS) is a recently developed approach in transcriptomics that 
uses deep-sequencing technologies.  Studies using RNA-seq have already changed our 
view of the extent and complexity of eukaryotic transcriptomes (Wang, Gerstein et al. 
2009).  This method is also more precise in measuring levels of transcripts and their 
isoforms than other methods.  RNA-Seq provides researchers with efficient ways to 
measure transcriptome data experimentally, allowing them to get information such as 
how different alleles of a gene are expressed, detect post-transcriptional mutations or 
identifying gene fusions (Maher, Kumar-Sinha et al. 2009).  Although we do not analyze 
RNA-seq datasets in this dissertation, the same methods developed for microarrays can 
be easily extended to this new technology. 
 
 
1.3 Yeast as a model organism   
Yeasts (Saccharomyces cereviciae) are eukaryotic, unicellular, microorganisms 
classified in the kingdom Fungi, with about 1,500 species currently described (Kurtzman 
2006), although some species with yeast forms may become multicellular through the 
formation of a string of connected budding cells known as pseudohyphae.   Yeast is also 
one of the most researched eukaryotic microorganisms in modern biology, where 
researchers have used it to gather information about the biology of eukaryotic cells and 
ultimately human biology (Ostergaard, Olsson et al. 2000).     
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Yeast was chosen as a model organism for many reasons. (1) It has low 
generation time. The average doubling time of a yeast culture is approximately 2 hours at 
30 oC, making it suitable for growing cultures in a short amount of time.  (2) Can be 
easily manipulated.  It can be easily transformed by either altering genes (addition or 
deletion) through homologous recombination.  The process of generating gene knockout 
strains is also largely simplified due to its ability to grow as a haploid. (3) DNA is highly 
conserved as an eukaryote. Yeast has similar complex internal cell structures of plants 
and animals, without the large amounts of non-coding regions from the DNA in higher 
organisms.  
Yeast has been used to study cell cycle (Spellman, Sherlock et al. 1998), various 
responses to stress (Gasch 2002; Werner-Washburne, Wylie et al. 2002), and entry into 
(Gasch, Spellman et al. 2000; Radonjic, Andrau et al. 2005) and exit from stationary 
phase (Martinez, Roy et al. 2004; Radonjic, Andrau et al. 2005).  In addition, yeast has 
been used to study many human diseases such as cancer (Simon, Szankasi et al. 2000; 
Marks, Rifkind et al. 2001) as well as the aging process (Ashrafi, Sinclair et al. 1999; 
Bitterman, Medvedik et al. 2003; Fabrizio and Longo 2003; McMurray and Gottschling 
2004; Piper 2006; Kaeberlein, Burtner et al. 2007). 
 
1.4 Stationary Phase cultures in yeast   
Stationary phase is an identifiable component of the culture cycle of 
microorganisms that is functionally defined as the time when there is no further net 
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increase in cell number (Fig. 3) (Werner-Washburne 1993).    When all external sources 
of carbon have been exhausted, cells enter stationary phase. 
 
Figure 3 - Time chart with the different phases leading to stationary phase.  Cells are 
initially in a glucose-rich media (YPD).  In what is known as exponential phase, cells 
reproduce rapidly through glucose fermentation until all glucose is totally consumed, 
reaching what is known as diauxic shift.  During post diauxic shift, cells change their 
metabolism to respiration, consuming ethanol as the primary energy source and 
reproducing very slowly.   
 
Different phases occur before stationary phase when yeast cells are grown in a glucose 
rich medium: exponential phase, diauxic shift and post-diauxic shift.   When cells in 
exponential phase have exhausted their sources of glucose, the diauxic shift occurs and 
they adapt from fermentation to respiration.  During the post-diauxic shift cell growth is 
highly reduced and after approximately seven days cells enter stationary phase as a result 
of carbon starvation (Lillie and Pringle 1980).   Stationary phase cultures have very 
different properties when compared to exponential phase cultures, such as a rate of 
translation 300 times slower (Fuge, Braun et al. 1994) , a rate of transcription three to 
five times lower than exponential phase (Paz, Meunier et al. 1999),  and are also highly 
resistant to stress (Werner-Washburne 1993).  As cells exhaust glucose and enter 
stationary phase, they differentiate into quiescent (Q) and non-quiescent (NQ) cells (Fig. 
4).  
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Figure 4 - Differentiation of quiescent and non-quiescent cell populations.  After 
performing gradient centrifugation in stationary phase, two types of heterogeneous 
populations are observed, an upper (non-quiescent) and a lower band (quiescent).   
 
 
1.5 Quiescent and non-quiescent cells 
 
Quiescence is the most common cell cycle state on earth (Lewis and Gattie 1991).  
Also known as G0, quiescence is critical to the survival of all organisms, where the 
efficiency of entrance and exit from quiescence provides a large selective advantage to 
microorganisms (Vulic and Kolter 2001) and also long-lived cells such as neurons 
(Morrison, Kinoshita et al. 2002) and egg cells (Bevers and Izadyar 2002).  Quiescent 
cells are also directly involved in tuberculosis (Parrish, Dick et al. 1998), cancer (Gray, 
Petsko et al. 2004), stem-cell maintenance (Suda, Arai et al. 2005) , wound healing 
(Chang, Yang et al. 2002) and sexual reproduction.     
Many phenotypic differences are present between quiescent and non-quiescent 
cell populations.  Quiescent cells are denser, more refractive, have thicker membranes, 
are stress resistant, 90% are daughters and are synchronous in the cell cycle.  On the other 
hand, non-quiescent cells are lighter, genetically unstable, less than 50% can divide and 
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show high levels of oxidative stress (Allen, Buttner et al. 2006) .  In summary, 
differences between stationary and exponential phase cultures as well as differences 
between quiescent and non-quiescent cell populations make the study of stationary phase 
cultures ideal for high-throughput flow cytometry. 
 
1.6 Computational challenges 
 With the latest developments in microarray and flow cytometry technologies, we 
face the ongoing challenges of analyzing large amounts of data, which have been 
growing at an exponential rate.  In order to achieve quick and reliable results, large 
datasets require optimal algorithms.   Although sophisticated computational procedures 
have been developed in recent years, many of these algorithms require either powerful 
computers or long processing time.  Moreover, powerful computational algorithms often 
provide questionable benefits in detecting additional biological information when 
compared to simpler and more efficient ones (Fodor, Tickle et al. 2007).  It is our goal to 
infer precise biological knowledge and at the same time to be computationally efficient. 
Unsupervised models, which are characterized by the lack of a dependent variable, 
present some of the main challenges in quantifying biological knowledge, requiring 
sophisticated methods to extract biological relationships from experimental data.   First 
we generate for all genes a measure of differential expression based on fold change in 
intensity (mRNA or protein abundance) and related t-statistics (Table 1).   
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Table 1 - Example of a microarray dataset with log-intensity values.  After averaging the 
fold change in log-intensity for every gene over all three arrays, an expected log fold 
change (exp. FC) for each gene is calculated.  After calculating the variance in log fold 
change intensity for every gene, the standard deviation is obtained and combined with the 
expected log fold change to generate a standard t-statistic. 
Gene (ORF) array1 array2 array3 gene var. exp.FC t‐stat
YAL001C   0.03 0.24 0.53 0.063 0.27 1.06
YAL002W   0.28 ‐0.03 0.62 0.106 0.29 0.89
YAL003W   0.25 0.17 0.46 0.022 0.29 1.96
… … … … … … …
YPR203W   ‐0.47 ‐0.58 ‐0.5 0.003 ‐0.52 ‐9.09
 
 
Next, differentially expressed genes are selected into gene lists based on ranking the 
measure of differential expression (Table 2).   Finally, the significance of gene lists is 
evaluated using performance measures.   Two common performance measures are often 
used:  Gene Ontology (GO) enrichment and gene list overlap (often referred to as 
“Concordance”).   
Table 2 - Example of microarray dataset in which a gene list is selected.  After sorting 
genes in descending order by expected log fold change intensity, the top 100 genes (blue) 
are selected into a gene list.   A similar gene list with the top 100 genes could have been 
selected based on sorting genes by the t-statistic.  
Gene (ORF) array1 array2 array3 gene var. exp.FC t‐stat
YIL101C   3.15 2.86 3.09 0.023 3.03 19.82
YML042W   2.92 2.74 2.9 0.010 2.85 28.92
YOL126C   3.31 2.34 2.84 0.235 2.83 5.83
YDR256C   2.63 2.62 3.11 0.078 2.79 9.95
YDR384C   3.02 1.77 3.2 0.607 2.66 3.42
YDR034W‐B 2.32 2.93 2.67 0.094 2.64 8.62
… … … … … … …
YJL016W   1.46 1.05 1.37 0.046 1.29 6.00
YLR136C   1.15 1.13 1.6 0.071 1.29 4.87
YDR545W   0.2 1.75 1.88 0.874 1.28 1.37
YJR019C   1.06 1.67 1.09 0.118 1.27 3.70
YPL147W   1.06 1.23 1.51 0.052 1.27 5.57
YBR294W   0.83 1.4 1.57 0.150 1.27 3.27
YPR184W   1.3 1.33 1.15 0.009 1.26 13.07
… … … … … … …
YNL052W   ‐2.57 ‐3.63 ‐2.73 0.327 ‐2.98 ‐5.21
YCR021C   ‐3.1 ‐3.28 ‐2.9 0.036 ‐3.09 ‐16.27
YBR054W   ‐3.02 ‐4.1 ‐4.64 0.680 ‐3.92 ‐4.75
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1.6.1 Gene Ontology enrichment 
Gene Ontology (GO) enrichment is a powerful tool to infer biological information.  
The basis of GO enrichment derives from measuring the association between gene lists 
and known biological knowledge based on Gene Ontology (GO) categories 
(GeneOntology ; Boyle 2004).  Genes are grouped into GO categories according to 
biological process, biological function or cell localization and then GO enrichment of a 
gene list is measured based on the number of genes in the list that belong to each GO 
category.  If the number of genes from a specific GO category is significantly higher than 
expected by chance, we say the gene list is enriched in that particular GO category.   
More specifically, when a GO category is enriched, it will have a significant p-value, 
giving us the confidence that our gene list is detecting groups of genes likely to belong to 
the same pathway. 
 
1.6.2 Concordance 
Concordance is a measure of reproducibility, often defined as the percentage of 
overlap between two gene lists.  The assumption is based on statistical measures to 
generate independent gene lists in which the overlap is significantly high.  Under these 
conditions, we can claim that a high overlap is indicative of major biological information 
(Lee, Kuo et al. 2000).  In other words, when the observed overlap is significantly higher 
than the expected overlap (where it is assumed no biological relationship exists), it is 
presumed that genes from the two lists describe similar biological patterns. 
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1.6.3 Association 
Association can be viewed as an extension of the concept of concordance 
applicable to understanding relations between microarrays or between genes.   Rank 
correlations are often applied as a robust measure of association (Kim, Rha et al. 2004).  
When using technical or biological replicates, microarrays with high rank correlation will 
provide a high confidence in the gene expression values.  Similarly when there is a high 
rank correlation between genes, these are more likely to be in the same pathway and 
therefore are more likely to be in the same GO category. 
 
1.7 Dissertation overview 
In microarray data, differences in log-fluorescence intensity between two 
conditions are calculated and then a measure of differential expression is generated and 
used to determine differentially expressed genes.  Researchers are often interested in the 
difference between a test and a control group, and similarly in differences between two 
test groups (different treatments).  Under such conditions the concept of differential 
expression can be further extended for optimal modeling in multi-dimensional datasets 
such as flow cytometry, where differences in protein expression are measured.   
The goal of this dissertation is to describe novel statistical methods based on 
unsupervised models applied to microarray and flow cytometry datasets.  These methods 
are compared against current methods using exclusively GO enrichment and concordance 
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as performance measures for different datasets.  The present work is divided into 5 
chapters.   
In chapter 2 we present applications of gene list overlaps between lists of 
differentially expressed genes and describe some of the main challenges that led the 
author to the development of more sophisticated algorithms described in chapter 4.  Two 
versions of these algorithms that test for differential expression are presented, followed 
by the description of an application that combines concordance and GO enrichment for 
multiple gene lists.  In addition, results from five yeast datasets are shown, together with 
a brief discussion.   Moreover, we also describe a method for measuring the significance 
of multi-dimensional gene list overlaps.  Summarizing, chapter 2 aims at describing some 
introductory ideas in measuring differential expression without getting into much detail.  
In chapter 3, a method is described for rapid and complete identification of 
heterogeneous cell populations from high-throughput flow cytometry data.   We present a 
novel measure, Slope Differentiation Identification (SDI) using flow cytometry-based 
protein expression.  SDI is used to quantity the rate of change in protein expression 
between two conditions (exponential and stationary phase of yeast cells), as a function of 
size or granularity of cells (Fig. 5).  
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Figure 5 - Scatter plots with slope as a multi-dimensional measure of fold change for two 
yeast mutants (CIT1 and ALG14).  The X axis (log side-scatter) is related to cell 
granularity, whereas triangles represent the corresponding average fold change in log-
intensity between stationary and exponential phase cultures for different levels of side-
scatter.   On the left hand side, there is a strong indication that the slope is greater than 
zero for the CIT1 yeast mutant strain.  On the right hand side, the slope for the ALG14 
yeast is very close to zero.  
 
Results showed SDI had superior GO enrichment performance when compared to 
other methods such as k-means clustering, average fold change and a method based on 
the bi-modality of the fluorescence intensity distribution, referred to as “Visual Two Peak 
Classification”.  Cell population differences were also validated using a gradient-
separation procedure in stationary phase followed by microscopy, where proteins with 
high SDI showed significant levels of differentiation between high and low density cells.   
In chapter 4 we describe a method that incorporates in a systemic way, the 
concepts of concordance and association in order to provide more accurate measures of 
differential expression.    In order to overcome the limitations presented by current 
methods in identifying differentially expressed genes, we developed a novel unsupervised 
statistical method called Calibration Regression Analysis of Microarrays (CRAM), in 
which empirical Bayes and regression calibration are systemically conjugated.  The main 
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novelty of CRAM is based on association between microarrays to model variance in gene 
expression as a function of the intensity levels within each microarray (Fig. 6).   
 
 
Figure 6   Scatter plots for each microarray under three different assumptions.   
Association is measured between sample log-fold change intensity and predicted log-fold 
change intensity from linear regression used by CRAM with remaining microarrays as 
explanatory variables.  Slopes are a transformation inversely proportional to the variance.  
In the top row, gene variances from every sample are assumed constant and equal to each 
other (identical slopes).   In the middle row, gene variances are assumed constant within 
each sample but different between microarrays (each microarray has a different slope).   
In the bottom row, gene variances are assumed to change within each microarray sample 
(sections within each sample have different slopes). 
 
CRAM gene correlation (CRAM-GC), a more sophisticated version of CRAM 
that incorporates gene correlation is presented and compared against other known 
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methods.  Results using 7 datasets are presented comparing CRAM and CRAM-GC 
against other methods.  Whereas CRAM showed a marginal improvement when 
compared to other methods, CRAM-GC had significantly superior performance. 
Chapter 5 summarizes results derived from chapters 2, 3 and 4 and describes 
potential improvements for the various methods presented.  We show how the concepts 
of association and reproducibility are present in all methods.  Similarly, these concepts 
also appear in gene list performance measures (GO enrichment and concordance), 
followed by a discussion of the relationship between variance in gene expression and 
concordance.   In addition, the benefits of modeling the difference between two 
conditions and improvements in modeling multi-dimensional and multiple conditions 
using high-throughput flow data are discussed. 
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 Chapter 2 – Applications 
 
2.1 Microarrays 
 
A DNA microarray is a technology that evolved from Southern blotting and is 
highly used in medicine and in molecular biology (Kulesh, Clive et al. 1987).  
Microarrays are generally classified into two types: two-channel (often referred to as 
cDNA or spotted microarrays) and one-channel (often referred to as oligonucleotide 
microarrays).  Each microarray is made of thousands of spots of short nucleic acid 
polymers.  These polymers can be a short section of a gene or other DNA fragment that 
are used as probes (usually 100 to 1000 bases long) to hybridize a cDNA (called target) 
under very specific conditions.   In order to detect hybridization of the probe to its 
complementary target sequence, the probe is labeled with a fluorescent marker.  Next, the 
level of fluorescence is quantified to determine relative mRNA abundance in the target.   
 
2.2 Differentially expressed genes 
Gene expression is the process by which information from a gene is used in the 
synthesis of a functional gene product.  Many steps in the gene expression process can be 
modulated, including the transcription, RNA splicing, translation, and post-translational 
modification of a protein.   Often these products are proteins, but in non-protein coding 
genes such as rRNA genes or tRNA genes, the product is a functional RNA (Huttenhofer, 
Schattner et al. 2005).   
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In a microarray experiment, several replicates (technical or biological) are 
generally used to obtain gene-expression measurements for every gene.  When technical 
replicates are used, all samples originate from the same tissue (humans) or the same 
culture (yeast) and are expected to be biologically identical.  Thus, differences in 
expression can be attributed to measurement error such as array to array variation, 
reagent variation and dye incorporation.   
When biological replicates are used, samples are expected to be biologically 
similar but not biologically identical.  One example of biological replicates in yeast is 
when each array has a different yeast culture belonging to the same strain, which were 
grown following the same strict protocol but nevertheless, have an additional source of 
variation (besides all the sources of variation present in technical replicates) which is 
attributed to differences between cultures as they grow.  We call the data in the 
experiments using technical or biological replicates as ‘homogeneous datasets’.  In 
addition, some experiments have each sample originated from a different strain (yeast 
deletion set), which makes biological variability among samples much greater when 
compared to biological replicates, and thus an additional source of variability (variability 
between strains) is introduced.  We call the data in these types of experiments 
‘heterogeneous datasets’. 
The primary reason for using replicates is to obtain a good level of significance 
for a combined measure of differential expression.  Once a combined measure of gene-
expression is obtained, it is used to generate lists of differentially expressed genes.  Lists 
of differentially expressed genes are then used to understand the corresponding 
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associations between mRNA abundance with development, disease and physiology 
(Eisen and Brown 1999).    
Ideally, if we performed the same experiment again, we would expect to obtain 
identical lists of differentially expressed genes (gene lists).  However, the many sources 
of variation present in gene-expression measurements are such that each time a 
microarray experiment is repeated, a different gene list is almost always generated.  A 
correct understanding of the variations in gene expression measurements in a microarray 
experiment is one of the main challenges in analyzing microarray data. 
 
2.3 Reproducibility  
As a basic requirement in microarray experiments, one must assume that although 
lists of differentially expressed genes generated by similar experiments are not identical, 
they should at least have high reproducibility.  However, recent studies have shown how 
unreliable microarray experiments can be: lists of differentially expressed genes, 
generated by similar experiments, have low overlap between them (Ivanova, Dimos et al. 
2002; Ramalho-Santos, Yoon et al. 2002; Tan, Downey et al. 2003).   
Parametric models, commonly used to measure differential expression are based 
in standard t-statistics, in which gene lists are selected by their p-value ranks. Similarly, 
non-parametric models such as Wilcoxon rank-sum tests are also used to generate 
measures of differential expression and their corresponding p-values (Shi, Tong et al. 
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2005; Shi, Reid et al. 2006).   In both parametric and non-parametric statistical models, 
gene lists generated by most methods have often resulted in low level of reproducibility.   
Extensive comparisons in recent work have shown that gene lists based on simple 
measures of differential expression such as fold change are often much more reliable than 
using more complex methods (Shi, Perkins et al. 2008).   Gene lists produced by fold 
change, are equivalent to gene lists using standard t-statistics, under the simplifying 
assumption that all genes have the same variance in gene expression.  Thus, it comes as a 
surprise why this simplification would generate much higher rate of reproducibility than 
the more ‘statistically’ sound standard  t-statistics (or other sophisticated statistics which 
assume different gene expression variances).  Many possible reasons such as small 
number of microarrays (Ein-Dor, Zuk et al. 2006) and sub-optimal standards in the 
manufacturing processes (Tan, Downey et al. 2003), have been suggested without a final 
conclusion, as to why this happens.    
The complexities involved in measurements of differentially expressed genes 
make it very likely that most gene expression models are based on incorrect assumptions, 
and thus incorrect p-values are generated.  Ranking genes using fold change, which is 
equivalent to assuming that the variance in gene expression is constant for every gene 
(homogenous variances), is also not a perfect assumption.  However, results based on the 
high reproducibility of gene list overlaps have suggested that the assumption of 
homogeneous variances is valid (Shi, Perkins et al. 2008).   In contrast, most methods 
which assume a different variance for every gene, model correctly the middle of the true 
distribution of the measure of differential expression, but often generate distortions when 
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modeling the tails.  Since selecting for lists of differentially expressed genes is a decision 
problem involving the tails, incorrect modeling of the tails will often produce sub-optimal 
gene lists.  
In order to overcome the limitations of standard t-statistics we developed a 
measure of differential expression based on ranks of gene expression for every 
microarray.  At the time our method was developed, the study by Shi and Perkins was not 
yet published, yet potential benefits of ranking each microarray based on the expression 
values had already been demonstrated    (Qin, Kerr et al. 2004) .   
       Our approach was tested on five yeast datasets using two channel microarrays and 
where RNA transcript abundance (gene expression) was measured and normalized using 
the software GenePix 6.0.  Each dataset consisted of yeast grown in stationary phase, 
where Q (quiescent) and NQ (non-quiescent) cell populations were separated from 
stationary phase cultures using density centrifugation.   
Our goal was to identify differences in gene-expression between Q and NQ and 
determine the GO biological processes that differ most between these two cell 
populations.  Since Q and NQ populations are sub-populations of stationary phase 
cultures, and are originated from the same subject, they are likely to be highly correlated 
and therefore a paired-design was used, where differences between transformed intensity 
values were taken for every Q/NQ pair of microarrays.  Although our method was tested 
in paired-design datasets it is also applicable to non-paired designs.  Summarizing, for all 
five datasets, each stationary phase culture gave rise to a pair of microarrays Q and NQ.   
For each corresponding pair of microarrays, differences in log-intensity between Q and 
23 
 
NQ were taken generating a corresponding array of paired differences in log-intensity 
(Table 1).  Datasets 1, 4 and 5 use biological replicates and therefore are classified as 
homogeneous, whereas datasets 2 and 3 have different strains (deletion mutant), and 
therefore are classified as heterogeneous. 
Table 1 - Description of datasets, number of arrays, number of paired-difference samples 
and total microarrays used in this study. 
DATASET Description # strains # cultures # arrays Q arrays NQ arrays
1 Biological replicates in SP ‐ BY4742 1 6 12 6 6
2 Different mutants in SP 80 80 160 80 80
3 Different mutants in SP 88 88 176 88 88
4 Biological replicates in SP ‐ BY4742 1 16 32 16 16
5 Biological replicates in SP ‐ S288C 1 10 20 10 10
 
In dataset 1, auxotrophic parental BY4742 strains were grown and separated into Q 
and NQ populations using a two-step density-gradient protocol (Allen, Buttner et al. 
2006).  As a result, 6 biological replicates (strains) from each Q/NQ population were used 
for a total of 12 microarrays.   The remaining 4 datasets (Aragon, Rodriguez et al. 2008) 
were processed similarly to dataset 1.  Due to the paired-design structure of our approach, 
we only used cell populations that separated into Q and NQ.   Dataset 2 had 80 
microarrays from the Q population and 80 from NQ, where each microarray measured the 
gene expression profile of a different yeast deletion mutant strain.  Dataset 3, similar to 
dataset 2, had 176 microarrays from 88 mutant strains.  Datasets 4 and 5 had 32 and 20 
microarrays respectively, and correspond to 16 auxotrophic parental (BY4742) strains 
and 10 wild type (S288C) strains (Table 1). 
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2.4 Ranked differential expression and generation of gene lists 
To identify the genes strongly associated between Q and NQ, we calculated for 
each gene a measure of differential expression between Q and NQ for all microarrays in 
the dataset.  If the measure of differential expression for a gene is positive, this gene is 
more highly expressed in the Q population. Conversely, if the measure of differential 
expression is negative, this gene is more highly expressed in the NQ population.  Our 
goal is to obtain gene lists from both Q and NQ and obtain GO enrichment from the 
Saccharomyces Genome Database Gene Ontology (Ontology ; TermFinder) as a measure 
of performance of gene lists.   
Two versions of the ranking method, the original version (version 1) and an 
improved version (version 2) were developed, with both having superior performance 
compared to standard t-statistics.   Both versions generate p-values based on t-statistics, 
with version 1 assuming different variances (after rank transformation) for every gene, 
and version 2 assuming the same variance (after rank transformation) for all genes.  
Initially we use these two versions to generate overall measures of differential 
expression, by combining transformed intensity values in all microarray pairs.  Next, for 
each version we generated gene lists of different sizes, and for each size we compared 
GO enrichment between the corresponding genes lists for each version for Q only (due to 
the fact that enrichment results for NQ were very unstable since each gene list from a 
different method produces vary different GO enrichment output, making them hard to 
compare).   Given the many limitations observed in the two versions, we developed a 
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much more powerful approach, Calibration Regression Analysis of Microarrays 
(CRAM), which is described in chapter 4. 
 
2.4.1 Generation of gene lists – algorithm version 1 
 The goal of the rank transformation used by this version is to minimize the effect 
of outliers, which is done by normalizing the data using a z-statistic transformation for Q 
similarly, a z-statistic transformation for NQ.  From this point on, the differences between 
the transformed       z-statistics for Q and NQ are taken for every pair of arrays.  These 
are then combined to generate a ranked based t-statistic.   The following is a step-by-step 
methodology for the microarray statistical ranking analysis.  For this purpose, let the 
dataset have 2k microarrays with k corresponding pairs of arrays of Q and NQ and n be 
the number of genes in the dataset.   
 
Ranked t-statistics - version 1 
For each array, 
1.  Replace each missing value with the median of the non-missing values in the 
array.  This enables us to manipulate the expression values for every gene and at the same 
time, minimize the impact of the replacing value (which is close to zero).  To minimize 
the bias in the data, we could also chose to add to the median, a small random error (such 
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as the mean error under a two way ANOVA), although in this particular case (using the 
five tested datasets), results were similar with or without the addition of a random error. 
2.  Rank each array in ascending order, generating a vector r of size n, where each 
element ri contains the rank of gene i within the array.  This transforms the data in each 
array into ranks, thus minimizing the effect of outliers. 
3.  For each gene i, its rank ri is transformed to a value pi between 0 and 1, through 
the expression 
pi = (ri − 0.5) / n 
4.  Use the inverse standard normal cumulative distribution function Φ -1 to 
transform pi into a corresponding z-statistic (standard Normal random variable with mean 
zero and standard deviation one), which is a robust statistic for every gene.  
zi = Φ -1(pi) 
 
For each corresponding pair j of complementary arrays (Q and NQ), 
5.    Denote zQj the vector of z statistics corresponding to the quiescent array and 
zNQj the vector of z statistics for the corresponding non-quiescent array. 
6.          Let dj = zQj  − zNQj , be a vector of differences with components dij 
corresponding to each gene i from array pair j.  This step generates the vector of 
differences between the transformed statistics. 
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For each gene i, 
7.  Calculate the average ui over all elements of dj  
ui  = k
1 ∑ =kj 1 dij 
8.   Denote si, standard deviation of dij across arrays for each gene i.  
9.          Let ai which is assumed to be a t-statistic with k − 1 degrees of freedom, be given 
by  
ai  = k  ui  / si,  
which is measure of differential expression for gene i. 
10.  Estimate a two tail p-value for gene i using T(ai , k - 1), the cumulative 
distribution function of a t-statistic with k - 1 degrees of freedom evaluated at value ai, 
given by 
p-valuei  =  2T(-|ai|, k -1)  
11.        At this stage, a p-valuei for each gene for the overall difference between Q and 
NQ has      been calculated. 
  This p-value will be used to determine if a gene is significantly differentially 
expressed. 
12.       Let C be the level of significance for every gene, specified by the user. 
13.       If p-valuei  <  C, and ai > 0, then the gene i is selected such that classi = “Q”.    
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This  generates a gene list where genes are differentially more expressed in Q than 
in NQ. 
If  p-valuei  <  C  and ai  < 0 then classi = “NQ” .   This generates a gene list where 
genes are differentially more expressed in NQ than in Q. 
 
Note: if p-value ≥ C, classi is not classified as “Q” or “NQ”, that is classi = blank. 
Note: steps 12 and 13 can be replaced if instead of selecting by p-value cutoff, we select 
for the m most significant p-values, where m is chosen arbitrarily by the user in a similar 
way as C. 
 
2.4.2 Generation of gene lists – algorithm version 2 
In version 1, which is based on a rank-transformed t-statistic measure of 
differential expression, we have achieved noise levels below those produced by a 
standard t-statistics.  However, in version 1, genes have different variances in the rank-
transformed gene expression values.   In order to generate an even more robust measure 
of differential expression, we developed version 2, which is based on the assumption that 
variances in the transformed expression values are homogenous, and therefore assumes 
every gene has a variance equal to the average of the variances over all genes.  This is 
equivalent to a fold change of the rank-transformed statistics.  We expect that at least 
under certain conditions (heterogeneous data) version 2 will be more robust than version 
1.   This superior robustness in heterogeneous data from version 2, comes from the fact 
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that even with rank-transformed data, gene variances (estimated by version 1) are highly 
distorted when large biological variability is present among samples. 
 
Ranked t-statistics - version 2 
Steps 1-7 as in version 1. 
For each gene i, 
8.          Let ai, which is assumed to be approximately a z-statistic, be given by  
ai  = ui  / k 
          This is equivalent to an expected fold change across array pairs. 
9.  Estimate a two tail p-value for gene i , Φ  the cumulative distribution function of 
the standard normal distribution is used: 
p-valuei  =  2 Φ (-|ai|)  
10.        At this stage, a p-valuei for each gene for the overall difference between Q and 
NQ has      been calculated.  
             This p-value will be used to determine if a gene is significantly differentially 
expressed. 
11.       Let C be the level of significance for every gene, specified by the user. 
12.       If p-valuei  <  C, and ai > 0, then the gene i is selected such that classi = “Q”.    
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If  p-valuei  <  C  and ai  < 0 then classi = “NQ” .    
Note: if p-value ≥ C, classi is not classified as “Q” or “NQ”. 
Note: steps 11 and 12 can be replaced if instead of selecting by p-value cutoff, we select 
for the m most significant p-values, where m is chosen arbitrarily by the user in a similar 
way as C. 
 
The choice of C, the level of significance for cutoff purposes, depends on how 
many false positives one is willing to accept. For example, let us assume our dataset has a 
total of 6,000 genes and that by using a cutoff level = 0.01, we get a total of 200 genes 
more highly expressed in Q than in NQ.  Under the assumption of a random scenario, the 
expected number of genes is equal to 60 genes (6000 x 0.01), which is the number of 
genes that could have been selected just by chance.  Thus, we can say that within the 200 
selected genes, we expect to have on average a total of 60 false-positive genes (genes that 
do not belong to the set of differentially expressed genes), leaving us with only 140 true 
genes.  This corresponds to a false discovery rate equal to 30% = (60/200).   To illustrate 
this example in a more formal way, we define false discovery rate as the probability that 
a gene is our list is not differentially expressed and we represent it by P(False | List).  So 
let: 
F represent the event that the gene is not truly differentially expressed,                             
T represent the event that the gene is truly differentially expressed,                                   
L represent the event that the gene belongs to the gene list.  
Using Bayes theorem, we have: 
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P(F | L) = P(L | F)P(F)/P(L) =  P(L | F)P(F)/( P(L | F)P(F) + P(L | T)P(T)  ).                   
Since we have no prior information about the probability that a gene is be either True of 
False, we let P(T) = P(F) = ½ and therefore P(F | L) simplifies to                                                                 
P(F | L) = P(L | F)/( P(L | F) + P(L | T)  ) =                                                                       
P(L | F) / P(L) = 1%/(200 / 6000) = 1%/(1 / 30) = 30%  
Assuming we had prior information that P(T) = 5%, that is, only 5% of the genome is 
truly differentially expressed, we would have: 
P(F | L) = (1%)(95%)/( (1%)(95%) + (200/6000)(5%)) = 85.1% 
The main idea is that since we had prior knowledge that it was much more likely for the 
gene not to be differentially expressed, the false discovery rate (FDR) became much 
higher.  The main limitation when selecting a gene list is to know which genes are the 
ones truly differentially expressed and which are not.  In the example described, we are 
unable to know which are the true 60 genes and the false 140 genes.   In this case, prior 
knowledge of the probability of a gene being differentially expressed can be highly 
informative and will generally lead to a smaller gene list (based on a p-value cutoff), 
when the prior probability of a gene being differentially expressed is low.  Since it is 
common for scientists to work with FDR < 15% (although this can vary depending on the 
experiment), and in the example where P(T) = 5%, we had an unacceptable FDR of 
85.1%, in order to keep FDR below 15%, we would have to make our p-value cutoff  
level under 3.1E-4.  A more detailed description of this framework, also referred to as 
False Discovery Rates (FDR) is found in (Benjamini 1995).    
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We should also be aware that any statement about false positives is based on the 
assumption that the p-values from the measure of differential expression are correct.  In 
almost all methods, including versions 1 and 2, there are distortions on the tails of the 
distribution of the measures of differential expression which leads to distortions of p-
value estimates (Fodor, Tickle et al. 2007).   Thus, inferences involving false positive 
rates must be viewed with caution in all differential expression methods.  The most 
common consequence of incorrect estimation of p-values in these tails, is the 
underestimation of p-values, leading to the generation of gene lists larger than they 
should be.  However, the accuracy of the p-values generated by version 2, based on the 
suggestion by (Fodor, Tickle et al. 2007; Reid and Fodor 2008) is largely improved, 
resulting in a better fit for the distribution tails, and thus, generating more accurate gene 
lists.  This improved modeling of the tail of the distribution of differential expression 
measures, is particularly useful when gene lists are generated based on p-value cutoffs.   
 
2.5 Measures of gene list overlaps 
 A measure of Gene Ontology category enrichment for a gene list can be 
generated using the software application GO Term Finder, in order to generate p-values 
for GO categories obtained from a gene list.  This software is used for measuring 
enrichment of a single gene list, which is equivalent to generating a p-value for the 
overlap between two sets of genes (the gene list originally generated and the set of genes 
belonging to a GO category).   GO Term Finder uses a simple statistical method based on 
the hypergeometric distribution, which is also used to measure the significance of the 
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overlap between two sets of genes (generated as a result of different treatments).  
However, valuable biological information can be obtained when three or more sets of 
genes are observed with their multiple pair-wise overlaps.  For this purpose we have 
developed a multi-dimensional approach to generating p-values for gene list overlaps.  
An example is described using the three sets of genes, which measures GO category 
enrichment using two gene lists (GO category set of genes + two gene lists). 
  
2.5.1 Generation of p-value for Gene Ontology (GO) categories 
Before describing the improved methodology to measure GO enrichment of a 
gene list, I will describe the standard methodology currently used by GO Term Finder.   
The goal of measuring GO enrichment is to infer biological knowledge based on the level 
of concentration of annotated genes present in our gene list.  For this purpose, a gene list 
is submitted to GO Term Finder and a p-value is returned for the most significant 
categories from a set of approximately 2000 annotated categories.  Next, I present an 
example of how the p-value is generated for a specific GO category. 
Let T denote the total number of genes (in the population) 
Let k be the number of genes of the GO category (the number of successes in the 
population) 
Let m be number of genes in the submitted gene list (sample size) 
Let l be the observed overlap, defined as the number of genes present in the overlap 
between the set of m genes from our submitted gene list and the set of k genes from the 
GO category.  In other words, l is the number of genes present in both the submitted gene 
list and the GO category. 
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Next, under the hypergeometric distribution assumption, let X be the random variable 
representing the unknown number of successes of the sample before the observed 
outcome of l successes.  The p-value after observing l genes belonging to the specific GO 
category is calculated by the following expression:  
p-value = ∑
=
},min{
 
mk
li
 P(X = i)  ,  
where P(X = i) , is given by the hypergeometric probability density function  
                                             P(X = i) = 
Calculating the p-value under the hypergeometric distribution assumption is not straight 
forward since we need to use the hypergeometric cdf (cumulative distribution function), 
which is not present in standard software (such as Microsoft Excel), thus more 
mathematically sophisticated software is required.  Thus, in order to estimate the p-value 
for the hypergeometric distribution, an approximation is used with very similar practical 
results.  The p-value for the hypergeometric distribution function can be approximated by 
a standard normal distribution through the following procedure: 
                                       E[X] = µ = mk / T                and    
                                      Var[X] = σ2 = µ( T – k)(T – m)/(T(T–1)) 
A z-statistic is calculated by    
z = (l – µ)/ σ,  
and a one-tail p-value is calculated by  
T
m
kT
im
k
i
C
CC −−
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p-value = 1– Φ(z) 
where Φ is the standard Normal cumulative distribution function.  The numerical 
example below clarifies the procedure. 
Example:  
Let T = 6300, the total number of genes of the data set.  
Let m = 630, the number of genes in the gene list. 
Let k = 200, the number of genes of a specific process, say “protein biosynthesis”. 
Let l = 100, the number of observed genes in the category “protein biosynthesis” 
belonging to our gene list.  Then, p-value = ∑
=
200
100
 
i
 P(X = i).  Since the proportion of the 
number of genes m in our gene list with respect to the total number of genes T is m / T = 
630/6300 = 10%.  Thus, we expect to have by the independence assumption, 10% of the 
total number of genes from the “protein biosynthesis’ category (10% of 200 = 20 genes) 
that belongs to our gene list.    
  The ratio lT/(mk) = (100)(6300)/((630)(200)) =  5, describes how much more 
concentrated the genes from the category “protein biosynthesis” are present in our gene 
list, compared to the expected number of genes from that category in a random gene list 
of size m.     Both measures (p-value and the ratio) should be used together as a way to 
obtain the enrichment of a gene list.  This approach may be extended by analyzing 
enrichment between overlaps of any pair of gene lists.       
A one-tail p-value is used (instead of two-tail) in all calculations of GO 
enrichment, since researchers are interested in genes from a gene list that are more highly 
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concentrated (greater than the expected overlap under a random scenario) in a GO 
category, and are rarely interested in genes from a gene list that are underrepresented in a 
GO category.  Moreover, if a researcher is interested in genes that are underrepresented in 
a particular GO category, it is unlikely that there will be enough statistical power to have 
a level of significance < 0.01.  As an example, let m equal the expected number of 
overlapping genes between our gene list and genes from a specific GO category.   We 
assume two scenarios: we observe a total of m+a overlapping genes in the first scenario, 
and a total of m-a overlapping genes in the second scenario.  The p-value in the first 
scenario is much more likely to be significant than in the second scenario.  This is due to 
the fact that the probability of a gene from our gene list to belong to a GO category in 
most cases will be much smaller than the probability of the same gene not belonging to 
the GO category.  Thus, the likelihood of observing an overlap with m+a genes, will be 
greater than the likelihood of observing m-a genes.  Moreover, we can easily adapt the p-
value generating algorithm to perform two-tail p-values.  
 
2.5.2 Measuring GO enrichment – two gene lists  
 
Here, we describe a novel method of measuring GO enrichment using two lists 
and compare it with the standard method using the ‘unknown’ GO category as an 
example.  The reason for choosing the ‘unknown’ GO category is because it is suited to 
detect novel genes not yet assigned to any particular known GO biological process (Fig. 1 
and 2).  Although we have chosen to illustrate our examples with the ‘unknown’ GO 
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category, this enrichment approach using two gene lists can be applied in a single step to 
all the thousands of GO categories.  
           
Figure 1- Example of a high overlap between the ‘unknown’ GO category and a single 
gene list.  A high overlap, which is an overlap significantly greater than expected overlap 
between two sets by the independence assumption (or by chance) is indicative of 
potential candidate genes for belonging to either a new GO category or an existing one.   
 
 
 
 
 
  
   High 
overlap 
 
  
 
Gene list unknown
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Figure 2 - Example of a high overlap among the ‘unknown’ GO category and two gene 
lists.  A high triple overlap, which is an overlap significantly greater than the expected 
overlap among 3 sets by the independence assumption (or by chance), is indicative of 
potential candidate genes for belonging to either a new GO category or an existing one.   
 
To illustrate the method, I will use the gene lists generated from datasets 2 and 3 
obtained from (Aragon, Rodriguez et al. 2008).  Datasets 2 and 3 generated respective 
gene lists A and B, of respective sizes 1080 and 1374 for genes classified as ‘Q’ with a 
total of 683 genes present in the overlap between both gene lists (Fig. 3). 
  High 
overlap 
 
 
 
 
 
 
Gene list A 
unknown
Gene list B
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Figure 3 – Venn Diagram for gene lists high in Q relative to NQ, obtained from datasets 
2 and 3.  The overlap of 683 genes, measures the number of genes present in both lists. 
 
There are 2540 genes in the “unknown” GO category annotated in the GO database, of 
which 232 genes are also present in the overlap of 683 genes between lists A and B.  So if 
we name list U as the list of all 2540 genes in the ‘unknown’ GO category, the set of 232 
genes will have a set theory representation as (A∩B)∩U.  Assuming both datasets have a 
total of 6359 genes each, under the random assumption, then we have 2504 x (683/6359) 
= 269 expected number of genes (within the ‘unknown’ GO category) in the overlap.  
Generating the ratio between the observed 232 genes and the expected 269 genes, we 
have a ratio of 232/269 = 0.86 < 1, which is less than the expected, under a random 
sampling, resulting in a non significant p-value. 
Let us assume that the population is the set of all genes from the ‘unknown’ GO 
category, corresponding to the lower portion of the Venn diagram (Fig. 4), resulting in a 
total of 591 genes, representing the overlap between: the overlap of the ‘unknown’ 
  
683 397
  
691
List A List B 
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category (2504 genes) and set A (385 genes), with the overlap between the ‘unknown’ 
category (2504 genes) and set B (438 genes),  which is represented by (A∩U) ∩(B∩U). 
                 
         
Figure 4 - Venn diagram for gene lists high in Q relative to NQ, obtained from datasets 2 
and 3.  The overlap of 232 represents the number of genes from the ‘unknown’ GO 
category present in sub list UA and also in sub list UB.   
 
Thus, sub list UA (385 genes which can be represented by A∩U), containing only genes 
from the ‘unknown’ GO category, and similarly sub list UB (438 genes which can be 
represented by B∩U).  The overlap between both lists is equal to 232 genes from the 
“unknown” category.  However, the expected number of genes in the “unknown” 
category in the overlap between lists A and B is equal to 385 x (438 / 2504) = 67.3.  This 
generated a p-value that was very significant (2.8E-100) and a ratio equal to 232/67.3 = 
3.45.  The main interpretation of this result is that a highly significant number of the 
same genes from the “unknown” category are present in both lists A and B, even though 
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the total number of genes (232) in the “unknown” category in the overlap between A and 
B is less than the expected overlap (269).  The representation in set theory of our list of 
232 genes in this scenario is given by (A∩U) ∩ (B∩U).  So it is interesting to notice that 
although the list of 232 genes can be represented by either (A∩B) ∩ U or by (A∩U) ∩ 
(B∩U), which are identical, both methods give totally different p-values, as a result of 
different expected overlaps (269 vs. 67.3), and therefore depend on the order which they 
are applied using the hypergeometric distribution function.  This is a characteristic of 
triple overlaps as well as higher dimensional overlaps which will be explained in more 
detail in section 2.5.3.     
Consider the following example using a normal approximation for the 
hypergeometric distribution, is presented in which we estimate the p-value for the overlap 
between sub list UA and the sub list UB.  
µ = mk / T = 385x438/2504 = 67.3  
σ2 = 67.3(2504 – 385)(2504 – 438)/(2504(2504-1)) = 47.00  , then  σ = 6.85 
A z-statistic is calculated from z = (l - µ)/ σ = (232 – 67.3) / 6.85 = 24.02 
The p-value using the normal approximation to the hypergeometric distribution, which is 
given by the expression 1 - Φ(24.02) = 8.5E-128, when compared to the p-value (2.8E-
100) using the true hypergeometric distribution, gives slightly different values, although 
for practical applications the conclusion is nearly the same, that is, the observed overlap 
of 232 genes is very significant, making these ‘unknown’ genes, good candidates for 
being classified into either a new GO category or an existing GO category.  In addition, 
the high significance of the observed overlap, indicate that these genes are likely to be 
correlated and therefore are good candidates to belong to the same pathway. 
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We should keep in mind that when using (A∩B) ∩ U to measure the significance 
of the triple intersection, we are asking the question: how significant is the number of 
‘unknown’ genes present in both datasets A and B?  On the other hand, when using 
(A∩U) ∩ (B∩U), the question is: how significant is the overlap between the ‘unknown’ 
genes from datasets A, and the ‘unknown’ genes from dataset B?   As we can see, these 
are two different questions, each generating a different expected value for the triple 
overlap, and therefore, different levels of significance are obtained for the observed 
overlap of 232 genes. 
 
2.5.3 Analyzing pair-wise and triple overlaps - Examples 
 
In the previous section, we illustrated an example of how the significance of the 
triple overlap (A∩B∩U) gave two different results, depending on the order in which the 
triple overlap was generated.  This is a typical characteristic of triple overlaps.  The 
overlap between three sets which is a natural extension of the commonly used overlaps 
between two sets, has many applications in biological problems.  To better explain 
applications involving triple overlaps, two practical examples are illustrated using Venn 
diagrams from data from  experiments in (Aragon, Quinones et al. 2006).   One of the 
main goals in these experiments was to determine if stress resistance in stationary cells 
would protect against oxidative stress (induced by the use of menadione).    
 In our first example, three treatments were used in stationary phase cultures where 
each treatment generated a list of differentially expressed genes, corresponding to genes 
that had ≥ 2 fold increase in transcript abundance relative to its initial condition (before 
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the treatment).   Three treatments were applied,  Proteinase K, 1 minute oxidative stress 
and 30 minutes exposure to high-temperature, in which three gene lists were generated.  
A Venn diagram with the overlap between three gene lists under the following three 
different treatments produced the following results (Fig. 5).  
 
Figure 5 - Venn diagram of transcripts that increased after three treatments were used: 
oxidative stress, proteinase K or high temperature. Transcripts were evaluated if they had 
a ≥2 fold increase relative to T0 cell lysates: abundance by 1 minute oxidative stress or 30 
minutes after oxidative stress or after proteinase K treatment. Transcripts were also 
required to have good spots in 80% of the time points. 
 
 A significant overlap was detected between the gene list generated using Proteinase K 
and the gene list generated by 1 minute oxidative stress.  Another significant overlap was 
detected between the genes list generated using Proteinase K and the gene list generated 
by a 30 minute exposure to increased temperature.  There was a significant triple overlap 
(Table 2).   
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Table 2 - P-values and ratios for all pair-wise overlaps and the triple overlap between 
gene lists obtained from the treatments Proteinase K, oxidative stress or high temperature.  
Ratios are defined as the observed overlap divided by expected overlap.  Total genes = 
6359. 
Overlap p-value Overlap expected Ratio 
(PK vs. OS) 1.5E-164 606 263.18 2.30 
(PK vs. HT)  1.1E-15 148 87.11 1.70 
(OS vs. HT) 3.1E-01 45 39.29 1.15 
(OS vs. HT) vs. PK 6.1E-09 37 18.3 2.02 
 
In another experiment from the same article, a comparison between three other 
treatments was tested.  The three treatments were Proteinase K, 1 minute oxidative stress 
and 30 minutes of oxidative stress.  Similar to our previous examples, the three 
treatments were used in stationary phase cultures where each treatment generated a list of 
differentially expressed genes, corresponding to genes that had ≥ 2 fold increase in 
abundance relative to its initial condition.     A Venn diagram showing the overlaps 
between all three treatments is presented (Fig. 6).        
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Figure 6 - Venn diagram of transcripts that increased by ≥2 fold increase in: abundance 
by 1 minute oxidative stress or 30 minutes after oxidative stress or after proteinase K 
treatment. Transcripts were also required to have good spots in 80% of the time points. 
 
In this case, all pair-wise overlaps were very significant.  The triple overlap was also 
significant although this was expected given the significance of all three pair-wise 
overlaps (Table 3). 
Table 3 - P-values and ratios for all pair-wise overlaps and the triple overlap between 
gene lists obtained from the treatments Proteinase K, 1 minute oxidative stress or 30 
minutes of oxidative stress for T0 cell lysates.  Ratios are defined as the observed overlap 
divided by expected overlap. Total genes = 6359. 
Overlap p-value overlap expected Ratio
(PK  vs. 1min OS) 2.4E-59 608 388 1.56
(PK vs.  30 min OS) 5.4E-49 710
 
493 1.44
(1min OS vs. 30 min OS) 2.9E-231 508 164 3.10
(PK vs. 30 min OS) vs. 1 min 
OS 1.6E-242 381 95.8 3.98
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329
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1650
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oxidative 
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2.5.4 Multi-dimensional overlaps 
We have seen some examples of how overlap analysis of gene lists is not limited 
to two dimensions and can potentially be extended to multiple dimensions.   Since 
biological systems are such that multiple interactions can occur, overlap analysis can be 
used to effectively detect some of the higher order interactions. We will illustrate some 
potential applications of multi-dimensional overlap analysis in detecting higher order 
interactions.  
 
  2.5.4.1 Measuring the significance of a triple overlap 
There are many ways of measuring the significance of a triple overlap between 
given gene lists A, B and C.  We can measure the triple overlap by six different ways: 
1. (A∩B) ∩ C 
2. (A∩C) ∩ B 
3. (B∩C) ∩ A 
4. (B∩A) ∩ (C∩A) 
5. (C∩B) ∩ (A∩B) 
6. (A∩C) ∩ (B∩C) 
In the first case, we can evaluate the overlap (A∩B) first and obtain the p-value 
of the overlap (A∩B) with C.  In the second case we can evaluate the overlap (A∩C) 
first and then obtain the p-value for the overlap (A∩C) with B, and finally, in the 
third case we can obtain the overlap between (B∩C) first and obtain the p-value of 
the overlap between (B∩C) with A.   Similarly, in cases 4, 5 and 6, we take the 
overlap between pair-wise overlaps.   The interesting fact is that all six cases will give 
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different p-values when measuring the significance of the triple overlap (A∩B∩C).   
This happens due to the fact that the expectation for the triple overlap is different in 
each one of the six cases. In order to define the significance of a triple overlap, we 
recommend choosing the most significant overlap between the six cases (the case 
where the expectation is the smallest).  We will show in subsection  2.5.4.3, how to 
optimize the selection of the most significant triple overlap. 
 
2.5.4.2 The non-greedy triple overlap 
 
  Let’s assume gene lists A, B and C, are such that all pair-wise overlaps (A∩B), 
(A∩C) and (B∩C) have insignificant overlap but (A∩B∩C) has a significant overlap.   
Although a multidimensional hypergeometric method is capable of detecting this type of 
overlap, they are quite limited since they do not use any knowledge of pair-wise overlaps.  
This limitation becomes clear in the example used in figure 4 with the ‘unknown’ GO 
category.  In this example, by assuming independence between sets A, B and U, we have 
an expected triple overlap equal to 6359 x (1080/6359) x (1374/6359) x (2504/6236) = 92 
which is still greater than the expected overlap (A∩U) ∩ (B∩U) which is equal to 67.  
Moreover, we should also keep in mind that if we want to detect the significance of all 
overlaps in higher dimensions, we might run into a computationally unfeasible problem.  
A more realistic approach, applied to three or more dimensions may be found in the 
example using the greedy triple overlap described next. 
 2.5.4.3 Greedy overlap analysis 
 In the greedy overlap approach to evaluating the significance of triple overlaps, we 
assume that in order for a triple overlap to be significant, there has to be at least one 
48 
 
significant pair-wise overlap.  To give a better idea, let us assume gene lists A, B, C are 
such that overlap (A∩B) is a significant overlap, but overlaps (A∩C) and (B∩C) are not 
significant, indicating that C does not interact with either A or B.  However, if the triple 
overlap (A∩B) ∩ C is significant, this implies that C interacts with the set (A∩B).  When 
the number of genes in each set A, B and C is large (>50), we can use a binomial 
approximation to estimate the expected values of overlaps.  We present how the 
expectation in calculated for each of the six cases previously described (Table 4). 
 
Table 4 – Approximate expectation using the binomial approximation for all six 
cases of triple overlaps.  In the first column, we have each triple overlap.  In the second 
column we have the corresponding formula for calculating the expected overlap (#A, #B, 
#C represent the total number of genes from each set; #T represents the total number of 
genes used in the experiment; #(A∩B), #(A∩C), #(B∩C) correspond to the number of 
genes in the pair-wise overlaps). The third column represents the expected overlap with 
the data from figure 5. 
expectation
1. (A∩B) ∩ C 18.3
2. (A∩C) ∩ B 27.1
3. (B∩C) ∩ A 20.0
4. (B∩A) ∩ (C∩A) 31.8
5. (C∩B) ∩ (A∩B) 23.5
6. (A∩C) ∩ (B∩C) 34.7
#(B∩A)#(C∩A)/#A
#(C∩B)#(A∩B)/#B
#(A∩C)#(B∩C)/#C
Triple Overlaps Expected triple overlaps
#(A∩B)(#C/#T)
#(A∩C)(#B/#T)
#(B∩C)(#A/#T)
 
Since the smallest expected overlap is 18.3 (from case 1), we select this as the optimal 
way to measure the significance of the triple overlap, and has a p-value equal to 6.1E-09.  
Had we chosen the largest overlap (from case 6), with expected overlap equal to 34.7, the 
corresponding p-value would have been equal to 0.32, which is not significant.  An 
interesting fact in this example, is that the p-values for the pair-wise overlaps (A∩B), 
(A∩C) and (B∩C) are respectively equal to 0.59, 1.3E-82, 1.6E-22, and at the same time, 
the overlap   (A∩B) ∩ C is the most significant triple overlap.   We can say that since the 
pair-wise overlap (A∩B) is the least significant, it also has a low expected overlap, 
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making it a good candidate to also generate a low expected triple overlap.   Thus, in a 
greedy approach, our best candidates to measure the significance of the triple overlap in 
the example in table 4, would be (A∩B) ∩ C and (A∩B) ∩ (B∩C), which correspond to 
cases 1 and 5,  (A∩B) ∩ C is equivalent to the least significant pair-wise overlap (A∩B) 
overlapped with the remaining set A, and where (A∩B) ∩ (B∩C) is equivalent to the 
least significant pair-wise overlap (A∩B) overlapped with the second least significant 
pair-wise overlap (B∩C).   
 Applying the step-wise procedure to the results obtained in figure 4, where the 
‘unknown’ GO category was used, if we take all three pair-wise overlaps (A∩B), (A∩U) 
and (B∩U), their corresponding p-values are respectively 9.9E-292, 4.9E-3 and 0.35.  
The least significant of these pair-wise overlaps is (B∩U), and therefore, this leaves us 
with two candidate overlaps: (B∩U) ∩ A or (B∩U) ∩ (A∩U). The corresponding 
expected overlaps for both   (B∩U) ∩ A and (B∩U) ∩ (A∩U) are equal to 74.4 and 67.3, 
and therefore since                 (B∩U) ∩ (A∩U) has the smallest expected triple overlap, it 
is the most significant triple overlap.  
The procedure of testing all combinations of three overlaps can be easily extended 
to testing all combinations of higher order overlaps.  However, we should remember that 
the number of overlaps (cases as presented in table 4) increases exponentially as a 
function of the number of dimensions.  Remembering that the step-wise procedure 
greatly reduces the number of overlaps in which the significance is measured, we can 
extend the procedure to higher order overlaps but at the same time we can be 
computationally efficient.   This is the goal of the greedy approach. 
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We can extend this procedure to higher order overlaps using the greedy approach, 
if we consider only overlaps such as cases 1 to 3 in table 4 (we do not include the more 
complex overlaps such as cases 4 to 6).      To illustrate the algorithm, we will use as an 
example a 5 dimensional overlap, using sets (gene lists) A, B, C, D and E.  
Let #T be the total number of genes in the experiment, and #A,#B,#C,#D and #E, 
be the total number of genes for corresponding sets A,B,C,D and E.  We first need to 
know if the multiple overlap A∩B∩C∩D∩E is underrepresented or overrepresented.  We 
define as overrepresented if the number of genes in the multiple overlap                           
#(A∩B∩C∩D∩E) > #A(#B/#T)(#C/#T)(#D/#T)(#E/#T), 
 which is the expected overlap assuming all 5 sets are independent.  Similarly we say 
A∩B∩C∩D∩E is underrepresented if  
#(A∩B∩C∩D∩E ) < #A(#B/#T)(#C/#T)(#D/#T)(#E/#T) . 
Let us assume A∩B∩C∩D∩E is overrepresented.  Then in order to maximize the 
significance of the multiple overlap, we should minimize the expected multiple overlap, 
which in this case is the expected fifth-order overlap.  To minimize the expected fifth-
order overlap, we chose the lower-order overlaps such that the expected overlap is the 
smallest as possible.  Let the lift between two sets S1 and S2 be defined as:  
Lift(S1,S2) =  #(S1∩S2)/(#S1(#S2/#T)) 
For example, if #(A∩B) < #A(#B/#T), meaning that the pair-wise overlap A∩B is 
underrepresented, then we have Lift(A, B) =  #(A∩B)/(#A(#B/T)) < 1.  Thus Lift 
between two sets can also be viewed as a measure of relative expectation.  In this 
example with 5 sets,  
#(A∩B)(#C/#T)(#D/#T)(#E/#T) < #A(#B/#T)(#C/#T)(#D/#T)(#E/#T), 
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which results in the fifth-order overlap (A∩B)∩C∩D∩E being more significant than the 
fifth-order overlap A∩B∩C∩D∩E.  Thus our goal is to find underrepresented (lift < 1) 
lower-order overlaps within A∩B∩C∩D∩E, such that the fifth-order expected overlap is 
the smallest.  In this example, (where the fifth-order overlap is overrepresented), we start 
by selecting from all pair-wise overlaps, the one with the smallest lift.   
Say the pair-wise overlap (A∩B) is such that its lift #((A∩B)/(#A(#B/#T)) is the 
smallest among all pair-wise lifts.   For each remaining set, in our case sets C, D and E, 
we select the triple overlaps with the smallest lift among the lifts: 
1-   #((A∩B)∩C) / #(A∩B)(#C/#T)  
2-   #((A∩B)∩D) / #(A∩B)(#D/#T)  
3 -  #((A∩B)∩E) / #(A∩B)(#E/#T)   
4-   #((A∩B)/(#A(#B/#T)) 
We notice that if the lift in case 4 is selected, it is because that lift is smaller than the lift 
in cases 1, 2 and 3.  This case is necessary since we want any additional grouping of sets 
to improve (decrease) the lift, thus, if no additional grouping improves the lift, we would 
chose the lift from the previous step, which is the smallest lift up to this point. 
Let case 2, be the overlap with the smallest lift.  The fact that  (A∩B)∩D is 
chosen, indicates that the triple overlap  (A∩B)∩D is underrepresented, since 
#((A∩B)∩D) is less than #(A∩B)(#D/#T) which assumes that the sets (A∩B) and D are 
independent.  Next we select the fourth-order overlap with the smallest lift between  
1 - #(((A∩B)∩D)∩C) / ( #((A∩B)∩D)(#C/#T) )  
2-  #(((A∩B)∩D)∩E) / ( #((A∩B)∩D)(#E/#T) ) 
3-  #((A∩B)∩D) / ( #(A∩B)(#D/#T) ) 
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Once again, case 3 assumes cases 1 and 2 had greater lift than in the previous step.  Say 
the smallest lift was case 2.  Finally we chose the last set C to generate the fifth-order 
overlap, so we chose between  
1- #(A∩B∩C∩D∩E)/ (#((A∩B)∩D∩E))(#C/#T) ) 
2- #(((A∩B)∩D)∩E) / (#((A∩B)∩D)(#E/#T) ) 
            Let us suppose case 2 (which was the lift from the previous step) was the smallest 
lift. Thus, we assume #(A∩B∩C∩D∩E)/ ( #((A∩B)∩D∩E)(#C/#T) ) is the smallest lift 
for the fifth-order overlap.  The main interpretation of this fifth-order overlap is that the 
fourth-order overlap (A∩B∩D∩E) is underrepresented, such that  
#(A∩B∩D∩E) < #(A∩B∩D)(#E/#T)  < #(A∩B)(#D/#T)(#E/#T) < 
#A(#B/#T)(#D/#T)(#E/#T) and therefore #(A∩B∩D∩E)(#C/#T) is the expected fifth-
order overlap and also a good candidate for being the smallest expected overlap (we can’t 
be sure it is the smallest since not all possible lower order combinations were considered, 
but the greedy solution is likely to be to be close to the optimal). 
  If the observed overlap A∩B∩C∩D∩E was underrepresented, we would select 
at each step for the set that maximized the lift, such that the fifth-order overlap had the 
largest expected overlap, and therefore our observed fifth-order overlap would be the 
furthest from the expected fifth-order overlap, resulting in the most significant fifth-order 
overlap. 
 
2.5.4.4 Variable gene list size overlaps 
 A more complex and potentially more powerful extension of overlap analysis results 
from applying a flexible cutoff for the selection of individual gene lists.  As an example, 
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consider selecting cutoffs c1, c2 and c3 used to create lists A, B and C, such that the 
significance of overlaps is optimized.  In this case, c1, c2 and c3 are optimally chosen 
such that the expected triple overlap is smallest and therefore the significance of the triple 
overlap is highest.  However, due to the multiple choices involving c1, c2 and c3, it 
would be required to adjust for optimistic p-values which occur as a result of testing for 
multiple cutoffs.   
    
2.6 GO enrichment evaluation of gene lists –  five datasets 
Enrichment for gene lists based on versions 1 and 2 were generated from datasets 
described in section 2.2.  Both versions were compared by selecting the most significant  
GO category of version 1 and then observing its performance when applied to version 2     
(Tables 5 to 9).  This will lead us to expect that in a random setting, version 1 will most 
often have a superior enrichment in relation to version 2.  In (Table 5), derived from a set 
of biological replicates, version 2 was significantly superior to version 1 for small gene 
lists (50 and 100), suggesting that the variance is likely to be distorted leading to inflated 
t-statistics.  Corresponding GO enrichment (not on table) for list sizes 50 to 400 for the 
standard t-statistics showed no GO enrichment. 
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Table 5 - Gene Ontology enrichment for most significant category in genes significantly 
higher in Q than in NQ.  Two tail p-values for the overlap between the two versions are 
obtained using the normal approximation of the Hypergeometric distribution.  Dataset is 
homogeneous. 
List size Go category version 1 version 2 # in cat p-value 
50 Transposition RNA-mediated 34 43 93 4.6E-13
100 Transposition RNA-mediated 44 69 93 2.1E-45
200 Transposition RNA-mediated 70 73 93 1.1E-01
300 Transposition RNA-mediated 71 77 93 2.3E-02
400 Transposition RNA-mediated 75 79 93 1.2E-01
Dataset 1 - Quiescent list
 
In (Table 6), version 1 appears marginally better than version 2.  Taking into 
consideration that the GO category was selected based on the lowest p-value from 
version 1 we can say that both versions have similar enrichment.   Corresponding GO 
enrichment (not on table) for list sizes 50 to 400 for the standard t-statistics showed no 
GO enrichment. 
 
Table 6 - Gene Ontology enrichment for most significant category in genes significantly 
higher in Q than in NQ.  P-values are obtained using the normal approximation of the 
Hypergeometric distribution.  Dataset is heterogeneous. 
List size Go category version 1 version 2 # in cat p-value 
50 not enriched
100 Response to oxidative stress 7 6 70 2.5E-01
200 Response to oxidative stress 12 8 70 2.6E-02
300 Response to oxidative stress 15 8 70 2.5E-03
400 Response to oxidative stress 16 13 70 1.5E-01
Dataset 2 - Quiescent list
 
The results in (Table 7) show that version 2 is significantly superior to version 1 for gene 
list sizes of 200, 300 and 400.  Taking into consideration that the GO category in version 
1 was selected based on the lowest p-value, we can say that version 2 is superior to 
version 1 on this dataset.   Corresponding GO enrichment (not on table) for list sizes 50 
to 400 for the standard    t-statistics showed no GO enrichment. 
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Table 7 - Gene Ontology Gene Ontology enrichment for most significant category in 
genes significantly higher in Q than in NQ.  P-values are obtained using the normal 
approximation of the Hypergeometric distribution. Dataset is heterogeneous. 
List size Go category  match v1 match v2 # in cat p-value 
50 Alcohol metabolic processes 10 10 160 5.0E-01
100 Cell biosynthetic process 27 35 1619 9.5E-02
200 Cell biosynthetic process 46 74 1619 5.5E-04
300 Cell biosynthetic process 71 105 1619 5.5E-04
400 Cell biosynthetic process 95 125 1619 6.0E-03
Dataset 3 - Quiescent list
 
 
The results in (Table 8) indicate version 1 is superior to version 2, and although GO 
categories in version 1 were selected based on the most significant GO category, the p-
value for the difference between the two versions is very significant, pointing to a clear 
superior GO enrichment performance for version 1.  Corresponding number of genes for 
each GO category (not on table) for list sizes 100 to 400 for the standard t-statistics were 
12, 15, 21 and 24 genes.  No GO enrichment was found for the t-statistics for list size 50.    
Table 8 - Gene Ontology enrichment for most significant category in genes significantly 
higher in Q than in NQ.   P-values are obtained using the normal approximation of the 
Hypergeometric distribution. Dataset is homogeneous. 
List size Go category version 1 version 2 # in cat p-value 
50 Generation of precursor metabolites 9 5 181 7.9E-03
100 Monocarboxylic acid metabolic process 8 4 128 2.1E-02
200 Monocarboxylic acid metabolic process 16 11 128 3.5E-02
300 Monocarboxylic acid metabolic process 21 13 128 8.6E-03
400 Monocarboxylic acid metabolic process 23 19 128 1.5E-01
Dataset 4 - Quiescent list
 
The results in (Table 9) indicate that version 1 is marginally superior to version 2.  
Taking into consideration that the GO category in version 1 was selected based on the 
most significant GO category, we can say that version 1 and 2 are roughly equivalent.  
Corresponding number of genes for each GO category (not on table) for list sizes 50 to 
300 for the standard t-statistics were 9, 67, 118, 149 genes.  No enrichment was found for 
the t-statistic for list size equal to 400.    
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Table 9 - Gene Ontology enrichment for most significant category in genes significantly 
higher in Q than in NQ.  P-values are obtained using the normal approximation of the 
Hypergeometric distribution. Dataset is homogeneous. 
List size Go category version 1 version 2 # in cat p-value 
50 Glycolysis 9 2 22 2.6E-33
100 Cell biosynthetic process 57 46 1619 3.6E-02
200 Cell biosynthetic process 117 75 1619 4.8E-07
300 Cell biosynthetic process 143 98 1619 7.8E-06
400 Cell biosynthetic process 163 114 1619 2.0E-05
Dataset 5 - Quiescent list
 
 
2.7 CONCLUSION – Novel Biological Results 
I have presented in this chapter the benefits of measuring the significance of 
multi-dimensional overlaps.  A useful application was described in which the significance 
of a triple overlap was used to determine the enrichment of a GO category and any two 
gene lists.  Another application measuring significance of triple overlaps involving 
experiments with 3 different treatments was also presented. 
On the topic of Gene Ontology enrichment of gene lists, we have shown the 
benefits of different approaches based on the hypergeometric distribution applied to Venn 
diagrams.    The main novelty derives from the combination of GO enrichment measures 
using two gene lists.  This approach was described as a variation of the triple overlap, in 
which we showed that very different p-values could result from the same triple overlap, 
depending on the order of pair-wise grouping.  Next we presented a general framework of 
how to detect multi-dimensional interactions by using multiple gene lists and described 
some interpretations of the results.   Moreover, a greedy approach was described that can 
identify multi-dimensional biological interactions in a computationally efficient way.   
On the topic of differential expression, different studies have shown conflicting 
results as to selecting gene lists assuming identical gene variances or selecting gene lists 
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based on standard t-statistics assuming different variances for every gene.  The results 
presented suggest that the ideal choice between equal or different gene variances is likely 
to depend on the dataset.    To address some of these limitations, we describe in chapter 4 
the CRAM algorithm which is far more sophisticated, and of which the latest version, 
CRAM-GS, incorporates correlations between genes into the model. 
In homogeneous datasets, versions 1 and 2 were roughly equivalent, whereas in 
heterogeneous datasets, version 2 was marginally superior.  The main reason version 2 
was superior in heterogeneous datasets is primarily due to its assumption of same 
variance for rank-transformed intensity values, which provides greater robustness than 
version 1, making it better to model the more noisy data, present in heterogeneous 
datasets.  We should also keep in mind that although versions 1 and 2 had similar GO 
enrichment performance, version 2 is better to infer measures of false positive rates, since 
it produces more accurate p-values.   
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Chapter 3 - SDI 
 
A statistical approach for detection of heterogeneous cell 
populations in high-throughput flow cytometry data 
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3.0 ABSTRACT 
 
Background.  Heterogeneous cell populations have previously been described as noisy.  However, 
recent studies have demonstrated that heterogeneity can be biologically significant. We present 
here an approach for rapid and complete identification of heterogeneous cell populations from 
high-throughput flow cytometry data.  We have developed a novel measure Slope Differentiation 
Identification (SDI) using flow cytometry-based protein expression, quantifying the rate of 
change in protein expression between two conditions (exponential and stationary phase) of yeast 
cells, as a function of cell size or cell granularity.  Results.  SDI had superior Gene Ontology 
enrichment when compared with other approaches such as k-means clustering and an approach 
based on the bi-modality of the fluorescence intensity distribution.  Cell populations were also 
validated using gradient-separation followed by microscopy, where proteins with high SDI 
Osorio Meirelles1, Sushmita Roy2, Ray Joe1, Phillip Tapia1, Chris Allen3, Mark B. Carter3, Susan M. 
Young3, Bruce S. Edwards3, Larry A. Sklar3,  Margaret Werner-Washburne1 
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measure showed significant levels of differentiation between high and low density cells.  
Conclusion.  Overall, our approach has identified novel protein expression patterns that 
differentiate quiescent and non-quiescent cell populations.   
 
3.1 INTRODUCTION 
 
Heterogeneous cell populations while sometimes thought of as “noisy” can 
sometimes result from important differences in cellular function.  For example, stationary 
phase cultures of the yeast Saccharomyces cerevisiae are known to be heterogeneous 
because of the formation of two populations of cells separable by density (Allen, Buttner 
et al. 2006; Aragon, Rodriguez et al. 2008). Other differences, such as age, cell cycle 
stage, cellular differentiation, and other non-random intra- and inter-cellular differences 
can contribute to heterogeneity (Raser and O'Shea 2004; Raser and O'Shea 2005).  
Flow cytometry is a technology used to detect fluorescent measurements of cells 
passing through a laser beam, where many thousands of cells can be measured, counted 
and selected (HTC).  The recent application of high-throughput flow cytometry using the 
yeast GFP-fusion library (Ghaemmaghami, Huh et al. 2003; Howson, Huh et al. 2005) 
(4159 strains, each with a green-fluorescent tagged protein), has led to new challenges in 
analysis of proteomics data. High throughput flow cytometry not only measures 
thousands of cells in each sample, but potentially hundreds of samples per minute, 
producing millions of data points per assay. Analysis of these massive flow datasets 
requires sophisticated computational methods for quantifying protein expression and 
detecting important population characteristics such as heterogeneity. 
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We developed a novel approach called Slope Differentiation Identification (SDI) to 
detect heterogeneous cell populations from high throughput flow cytometry data. Our 
approach detects heterogeneity by modeling change in fluorescence intensity from two 
conditions as a function of cell size or granularity.  
We applied SDI to detect heterogeneous cell populations in a flow cytometry dataset 
measuring expression levels of ~4000 yeast GFP-fusion strains in stationary phase. 
Because stationary phase samples are known to be heterogeneous this dataset served as a 
good candidate for validation of SDI as well as discovery of novel strains exhibiting 
heterogeneity.   
We compared SDI against other approaches for detecting heterogeneity, including 
visual inspection and three-dimensional k-means clustering. For each approach we tested 
if predicted heterogeneous strains were statistically overrepresented in biological process 
categories (GeneOntology). SDI outperformed these approaches, generating 
heterogeneous candidate strains that were more overrepresented in biological process 
categories, than other approaches. Additional validation with stationary phase cultures, 
showed SDI-identified GFP-fusion strains to be strongly associated with heterogeneous 
populations identified using gradient-separation and microscopy. 
  Overall SDI is a computationally efficient approach for analyzing flow cytometry 
measurements of thousands of proteins, and detecting strains that are statistically 
overrepresented in several biological processes. SDI-identified strains are also highly 
likely to form heterogeneous cell populations identifiable by microscopy. 
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3.2 METHODS 
3.2.1 Generating the data 
Slope Differentiation Identification (SDI) was applied on two high-throughput 
flow datasets measuring fluorescence intensity of GFP-fusion strains from stationary and 
exponential phase cultures.  Each dataset contained three technical replicates for each of 
the 3941 GFP-fusion strains.  A HyperCyt®  autosampler (Edwards, Oprea et al. 2004; 
Young, Bologa et al. 2005) controlled by HyperSip  software was used to measure 
fluorescence intensity of approximately 30,000 cells (events) per sample at a sampling 
rate of approximately 40 samples/min.  The software package IDLQuery (IDLQuery) was 
used to capture and analyze data, generating output flow measurements for every strain.  
Each sample had approximately 30,000 three-dimensional measurements of fluorescence 
intensity, forward-scatter (cell size) and side-scatter (cell granularity). Overall, 
approximately 24,000 samples were analyzed in both datasets. 
 
3.2.2 Visual identification of two-peak samples   
The software package IDLQuery was used to generate fluorescence intensity 
histograms for each GFP sample. Each sample was visually classified as either two-peak, 
if it had bi-modal distribution of fluorescence intensity, or as one-peak, if the distribution 
of fluorescence intensity was uni-modal.  
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3.2.3 Slope Differentiation Identification (SDI) method for unsupervised two-peak 
detection  
SDI can be generated using either one of the two flow-cytometric measurements: 
side-scatter and forward-scatter. We will describe only the SDI measure using side-
scatter since the procedure for forward-scatter is identical. To generate SDI measure, we 
grouped side scatter measurements from the SP dataset into 100 bins.  Side-scatter 
measurements from exponential phase were grouped into similar 100 bins.  Although we 
chose to group by 100 bins, several different numbers of bins were tested with very 
similar results for number of bins between 10 and 200.  Next, for every sample, profiles 
of average log intensity and average side scatter were generated, separately for stationary 
and exponential phase datasets using all events within each bin.    
The SP samples were combined with their corresponding exponential samples, 
forming three sample-pairs* (one pair for each technical replicate). To obtain SDI for 
stationary phase, we first calculated the fold change in log fluorescence intensity by 
subtracting average log intensity in exponential phase from average log intensity in 
stationary phase. This was done for each sample for all bins, generating a profile of fold 
change as a function of side scatter, in stationary phase.  After excluding GFP strain 
which had bad samples in either SP or exponential phase, the initial GFP library of 4159 
strains was reduced to 3941 strains. 
 
 
 
 
 
*The term “sample” and “sample-pairs” both refer to a strain carrying a specific GFP-fusion protein.  A sample can be cells from a 
stationary or an exponential culture, whereas a sample-pair refers to information from both stationary and exponential phase for a 
strain carrying the same GFP-fusion protein. 
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We have regressed fold change in log intensity on the average log side scatter using 
only bins with ≥50 events in both stationary and exponential datasets, in order to assure 
statistical significance of fold change for each bin (we also tested other cutoff values 
from 100 to 500 in steps of 50, with similar results).  Selecting bins with ≥50 events 
assured statistical confidence in estimations of average log-intensity and average log 
side-scatter. Regressing fold change in log intensity on the average log side-scatter, 
generated a slope for each sample-pair per replicate, resulting in three slopes for each 
GFP-fusion strain.   These slopes were shown to have high reproducibility (please see 
supplemental materials for more details). 
The median mi is calculated for each gene (GFP) i, over the three slopes.  An 
approximate z-statistic is obtained for every sample by subtracting each mi from its mean 
over 3941 genes and dividing the difference by the standard deviation of mi over all 3941 
genes.  This z-statistic is the numerical value for SDI.  Similarly, SDI for exponential 
phase was obtained, where fold change was calculated by subtracting average log 
intensity in SP from the average log intensity in exponential phase, followed by linear 
regression.   
3.2.4 k-means clustering 
  k-means clustering was performed on each dataset using the ratio of average log 
intensity to average log forward-scatter. The number of clusters for k-means was pre-
specified as 20 (the number of clusters was tested from 5 to 100 in increments of 5 with 
very similar results). The average profile for each cluster was computed, followed by 
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visual identification of clusters with broad or jagged profiles. These clusters were 
expected to contain proteins with multiple populations. This analysis identified one 
cluster of 80 samples from stationary phase, and one cluster of 99 samples from 
exponential phase. Samples from these clusters were compared against candidate 
heterogeneous samples from other methods. 
3.2.5 Average fold change 
Average fold change is frequently used in microarray data.  Similar to SDI, but 
using limited to a single dimension (fluorescence intensity), the average log fluorescence 
intensity over all cells (events) from each GFP strain was obtained for each sample for 
both SP and exponential phase.  Next, for every GFP, we subtracted the average log 
intensity from exponential phase, from the average log fluorescence intensity from SP, 
and generated the average fold change measure, for each sample.  We define the average 
fold change for every gene i  as the median over all 3 samples of the average fold change 
measure.   
 
3.2.6 Identification of GFP strain lists and GO process categories  
Four approaches were used to identify proteins with heterogeneous samples: SDI, 
visual identification, k-means clustering and average fold change.  For visual 
identification of two-peak samples approximately 8000 samples were examined using 
IDLQuery. Two sample lists were generated: 147 SP, two-peak samples (SPV) and 45 
exponential phase two-peak samples (EPV).  For k-means clustering two sample lists 
were generated: (SKM) with 80 SP samples and (EKM), with 99 exponential phase 
samples.   Lists generated by SDI measure (SDI) and average fold change (AFC) were 
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compared with lists generated by the other two approaches for Gene Ontology (GO) 
process enrichment.  Lists from SDI were generated by sorting according to decreasing 
SDI measure and then selecting top n samples.  n depended on the type of comparison 
(See Results).   Similarly lists from average fold change were obtained.  
 After sample lists were generated, each list was evaluated using GO Term Finder 
(www.geneontology.org), available at Saccharomyces Genome Database.  For each list, 
p-values for GO biological process categories were obtained and the most significant 
categories of each list were selected with their respective p-values (for more details about 
p-value generation, please see supplemental materials).   
 
3.3 RESULTS 
3.3.1 SDI and two-peak plots 
The histogram distribution obtained from IDLQuery shows the distribution of 
fluorescence intensity of two yeast GFP-fusion strains from stationary–phase cultures 
(Fig. 1).  
 
Figure 1 - Histograms of flow cytometry output comparing log fluorescence intensity vs. 
number of events for two yeast GFP-fusion strains in SP.  CIT1 shows a two-peak 
distribution whereas ALG14 shows a single peak.   
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Similarly, the histogram distribution of fluorescence intensity of the same two yeast GFP-
fusion strains from exponential–phase cultures is shown (Fig. 2).  
 
 
 
Figure 2 - Histograms of flow cytometry output comparing log fluorescence intensity vs. 
number of events for two yeast GFP-fusion strains in exponential phase.  CIT1 and 
ALG14 show single peak distributions.   
 
These were the types of outputs used to visually detect samples with two peaks, i.e., 
bimodal distribution of fluorescence intensity.  The same yeast strains from both 
exponential and stationary phases were compared using two scatter plots: one displaying 
fluorescence intensity as a function of side scatter (Fig. 3), and the other displaying the 
fold change in fluorescence intensity as a function of side scatter (Fig. 4).  As can be 
seen, fluorescence intensity of CIT1 changes at a higher rate in SP than in exponential 
phase. This difference is captured by the SDI measure (Fig. 4), which is high (0.81) for 
CIT1 and close to 0 for ALG1 (0.02). Through this analysis, we determined that a 
significant slope is strongly associated with strains that have bimodal distributions of 
fluorescence intensity.  This association between large slope values and bimodal intensity 
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distributions is exploited by SDI to detect heterogeneous cell populations in a high-
throughput fashion.    
Figure 3 - Scatter plot of log side-scatter vs. log fluorescent intensity.  Triangles 
represent the average log fluorescence intensity in SP and circles represent the average 
log fluorescence intensity in exponential phase. To assure statistical significance, each 
bin in the both plots was selected only if it had at least 50 events in both datasets. 
Figure 4 - Regression scatter plot of log side-scatter vs. log fold-change in fluorescent 
intensity.  Triangles represent average fold change in log intensity between stationary and 
exponential phase. To assure statistical significance, each bin in the both plots was 
selected only if it had at least 50 events in both datasets. 
 
  To determine the significance of the slope in figure 4, a weighted linear 
regression, where each bin is assigned the weight which is the minimum of the number of 
cases for that bin, between SP and exponential.  Similarly, we estimate the weighted of 
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the slope, and by divide the slope by its standard deviation, to obtain a t-statistics and its 
corresponding p-value.  However, gene lists produced based on ranking by slopes turned 
out to have far better enrichment, than gene lists produced by ranking by t-statistics, and 
thus we chose to rank by slope (which is the same as ranking by t-statistics, but assuming 
all slopes have the same variance). 
 The modeling of the fold change for each bin as a function of side-scatter can be 
further improved by assuming a non-linear association.  This non-linear association is 
suited to model saturation regions which fold change will tend to be constant for high 
levels of side-scatter, such as the 5 triangles in the extreme right of figure 4.   One simple 
non-linear function to model the relation between log-fold change in intensity and log 
side-scatter is f(x) = a( 1 – exp(– (bx+c)) ), where x is the log side-scatter which has an 
upper bound (asymptotic) at a, and will look like the line a(bx+c) near the region in 
which bx+c is close to zero, that is, in the neighborhood where x is close to –c / b.   This 
function also has an interesting property which is that it also models the local slope (slope 
in this neighborhood), which is equal to ab and is a non-linear version of SDI for every 
GFP, and would also be used to rank GFPs and produce gene lists.  However, in this 
dataset, genes lists generated by ranking genes by ab was very similar to gene lists 
generated by ranking by the linear SDI, and therefore no additional benefit was observed 
for using this non-linear model.                                                        
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3.3.2 Biological process enrichment 
Enrichment performance using Gene Ontology (GO) biological process categories 
was obtained for SP visual two peak list (SPV, 147 GFP-fusion strains) and same sized 
lists (147 GFP-fusion strains) generated using two SDI measures SDI_SS (which uses 
side-scatter), SDI_FS (which uses forward-scatter) and average fold change (AFC) for SP 
(Table 1).   Since SDI_FS was very similar to SDI_SS, after table 2 until the end of this 
chapter, we user only to SDI_SS, and for simplicity we will refer to it as SDI. Also for 
simplicity, all p-values from the tests will be one-tail p-values until the end of this 
chapter. 
Table 1 - Gene Ontology biological process enrichment comparison for stationary visual 
two-peak list (SPV), SDI_SS (SDI side-scatter), SDI_FS (SDI forward-scatter) and 
(AFC) of the same size (147 samples).   
GO CATEGORY SPV AFC SDI_SS SDI_FS
generation of precursor metabolites and energy         7.9E‐21 6.8E‐15 3.1E‐32 8.4E‐30
oxidative phosphorylation                                              1.6E‐17 4.0E‐19 2.5E‐24 2.5E‐24
cofactor metabolic process                                            1.4E‐13 1.0E‐12 2.1E‐18 2.0E‐15
 
GO enrichment of SDI_SS and SDI_FS lists was significantly superior compared to 
SPV and AFC.   Similarly, GO enrichment was generated for the k-means list (SKM) and 
same size lists (80 GFP-fusion strains) using SDI and AFC (Table 2).   GO enrichment of 
SDI_SS and SDI_FS lists was significantly superior to SKM and AFC.  
 
Table 2 - Gene Ontology biological process enrichment comparison for stationary k-
means (SKM), SDI_SS (SDI side-scatter), SDI_FS (SDI forward-scatter) and (AFC) of 
the same size (80 samples).   
GO CATEGORY SKM AFC SDI_SS SDI_FS
generation of precursor metabolites and energy         1.1E‐08 1.6E‐11 2.7E‐24 5.7E‐27
oxidative phosphorylation                                              1.4E‐10 1.4E‐13 2.7E‐22 2.0E‐20
cofactor metabolic process                                            3.1E‐07 7.0E‐12 2.2E‐17 4.5E‐15
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GO enrichment of SDI_SS and SDI_FS lists was significantly superior compared to SKM 
and AFC. In Table 3 we show the significance between the number of genes from SDI, 
compared to SPV and AFC, for results from Table 1. 
Table 3 – Number of genes in each GO biological process category present in the gene 
list using different approaches (SDI, SPV, AFC).  In column 6 we have the p-value under 
the normal approximation for the hypergeometric distribution that SDI is significantly 
greater than SPV and similarly in column 7 we have the p-value that SDI is significantly 
greater than AFC. 
GO CATEGORY GFP in cat SDI SPV AFC SDI.vs.SPV SDI vs. AFC
generation of precursor meta 140 45 35 29 5.0E‐04 6.9E‐08
oxidative phosphorylation    30 21 17 18 2.5E‐03 1.8E‐02
cofactor metabolic process   134 32 27 26 4.6E‐02 2.2E‐02  
In Table 4 we show the significance between the number of genes from SDI, compared to 
SPV and AFC, for results from Table 2. 
 
Table 4 - Number of genes in each GO biological process category present in the gene 
list using different approaches (SDI, SKM, AFC).  In column 6 we have the p-value 
under the normal approximation for the hypergeometric distribution that SDI is 
significantly greater than SKM and similarly in column 7 we have the p-value that SDI is 
significantly greater than AFC. 
GO CATEGORY GFP in cat SDI SKM AFC SDI.vs.SKM SDI vs. AFC
generation of precursor meta 140 31 15 19 7.2E‐13 5.5E‐08
oxidative phosphorylation    30 17 10 12 2.0E‐11 1.2E‐06
cofactor metabolic process   134 24 14 19 7.7E‐06 1.5E‐02  
We did a similar GO enrichment analysis for lists from exponential phase cultures. 
However, the enrichment performance for all three lists was similar and much lower than 
lists from SP. For example, p-value for the best category of visual exponential two-peak 
list was > 5.7E-05, of k-means list was > 5.0E-04, of average fold change was > 5.0 E-04 
and for SDI > 1.8E-4. These results suggest that heterogeneous cell populations are more 
likely to occur in stationary than in exponential phase cultures.   
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3.3.3 Marginal enrichment  
Marginal enrichment comparisons between two lists of the same size are used to 
identify the enrichment of each list after excluding the overlap between them, measuring 
the exclusive enrichment of each list.  Excluding from SDI the samples present in the 
overlap of SDI and SPV resulted in a list of 52 samples, which we call SDI–SPV.  
Similarly, excluding the same overlap from SPV resulted in a same size list called SPV–
SDI.  Next we selected a random list of the same size as a control for enrichment 
comparisons.  The three lists were submitted to GO Term Finder and enrichment for the 
most significant 20 categories of each list was ranked by                 –log(p-values) and 
compared.  Marginal enrichment was also compared between SDI and AFC with lists of 
size 95 and similarly, comparisons between SDI and SKM with list sizes of 46 samples 
were performed (Fig. 5). SDI–SPV list is more enriched than SPV–SDI list for all 
category ranks.  SDI–AFC list is more enriched than AFC–SDI for all category ranks.  
This is illustrates the benefits in using two-dimensional fold change, which is SDI, 
compared to using a single dimensional fold change, which is AFC.  Furthermore, SDI–
SKM shows a high level of enrichment, whereas SKM–SDI shows enrichment no 
different from random.  
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Figure 5 – (1) Line plot comparing SP marginal lists, SDI vs. visual 2 peak list (SPV). 
Standard errors for the –log(p-value) from random lists are not shown since they are very 
small. (2) Line plot comparing SP marginal lists, SDI vs. average fold change (AFC). (3) 
Line plot comparing SP marginal lists, SDI vs. k-means (SKM). Standard errors for the –
log(p-value) from random lists are not shown since they are very small.    
   
 
 
3.3.4 Intersection analysis of compared approaches 
We compared the overlap between lists generated by each approach for 
heterogeneous sample detection. We used a p-value cutoff of 0.01 to generate an SDI list 
of 78 samples. Next, a triple overlap between this SDI list, stationary-phase two-peak 
SPV and stationary-phase k-means SKM lists was obtained, which had 33 samples (Fig. 
5). 
0
10
20
30
1 5 9 13 17
GO category rank
- l
og
(p
-v
al
ue
)
SDI - SPV
SPV - SDI
RANDOM
0
5
10
15
20
25
30
1 5 9 13 17
GO category rank
- l
og
(p
-v
al
ue
)
SDI - AFC
AFC - SDI
RANDOM
0
10
20
30
1 5 9 13 17
GO Category rank
-lo
g(
p-
va
lu
e)
SDI - SKM
SKM - SDI
RANDOM
(1) (2) 
(3)
73 
 
The overlap between SDI and SPV (39) excluding the triple overlap is greater than 
the overlap between SDI and SKM (1) excluding the triple overlap, and similarly, greater 
than overlap between SPV and SKM (9) excluding the triple overlap.  This suggests a 
higher similarity between SDI and SPV. Because SPV was generated via visual analysis, 
and deemed to be of high quality, the high similarity of SDI list further indicates SDI to 
be a reliable approach of detecting heterogeneous samples. 
 
3.3.5 Microscopic examination of gradient-separated cells  
In order to provide a stronger validation of our candidate heterogeneous samples, we 
performed phenotypic analysis using density separation and microscopy, of 35 high 
confidence candidates.  These 35 samples included the triple overlap (33 samples) of all 
three approaches and two additional samples corresponding to second and third highest 
SDI measures (the sample with highest SDI measure was already in the triple overlap).  
Density separation of GFP-fusion strains for each of the 35 samples resulted in an 
upper and lower fraction in stationary phase. For every sample  both upper and lower 
fractions were isolated, giving rise to 70 cultures: 35 cultures containing high-density 
cells and 35 cultures containing low density cells, corresponding to 35 GFP-fusion strain 
pairs.  For simplicity we will use the term GFP-fusion strains instead of GFP-fusion 
strain pairs. Next, each GFP-fusion strain was compared with visual microscopy to 
identify differences in GFP-fusion localization among the high and low density cells. 
This resulted in 20 GFP-fusion strains with visual differences in fluorescence between 
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their corresponding high and low density populations.  Majority of these 20 strains had a 
high SDI score (pvalue < 1.1E-4). 
  In order to provide additional comparison of the approaches, samples that were 
exclusively identified (Fig. 6) by each approach were analyzed microscopically. 
Specifically, we selected 5 (out of 37), 5 (out of 67), and 5 (out of 6) samples uniformly 
at random from two peak visual analysis, k-means and SDI, respectively. After visual 
inspection, we used the following classification for each GFP-fusion strain: 1 if there was 
clear visual fluorescence difference, and 0 if there was no difference (Table 5).  SDI 
showed differences in fluorescence in all 5 GFP-fusion strains, followed by SPV with 3 
differentiated GFP-fusion strains out of 5.  None of the samples from SKM had 
differences in fluorescence.   
Inspection of GO categories for the list of 35 samples identified ‘Carboxylic acid 
metabolic process’ to be one of the highly significant categories. Interestingly, all strains 
from our list that were annotated with Carboxylic acid metabolic process (9 out of 35) 
had visual differentiation in fluorescence intensity. This was highly significant (p-value 
equal to 1.4E-8) and suggests that  
proteins involved in Carboxylic acid metabolic process are highly likely to form 
heterogeneous populations.  
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Figure 6 - Venn diagram of the overlaps using SDI, SPV and SKM.  Overlap between 
SPV and SDI is much higher than overlaps with SKM. 
 
Table 5 - Visual microscopy identification of fluorescence differentiation of non-
overlapping GFP-fusion strains. A ‘1’ represents visual differentiation in fluorescence 
intensity and ‘0’ represents no differentiation.   
 
 
 
 
 
 
 
 
33
37  1 6
67
9 38
SKM SDI 
SPV 
SDI Diff SPV Diff SKM Diff
TEF1 1 ATP1 1 MDV2 0
URA1 1 MES1 0 UBC1 0
TDH3 1 PRT1 0 NMD4 0
ATP10 1 ABF2 1 PET18 0
SDH4 1 PRE3 1 ENP1 0
Random sample of non-overlapping genes (GFP-fusion)
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3.4 DISCUSSION 
Heterogeneous cell populations can be detected using different methods, with every 
method having its own limitations.  For example, gradient separation can identify 
heterogeneous cells populations based on density, but not if heterogeneous populations 
cannot be separated on the basis of density. Visual detection of two-peak samples can 
detect heterogeneity from a single condition, but it is not clear how to detect 
heterogeneity across two conditions. Further, this approach requires manual inspection, 
which does not scale when data from multiple conditions are available.  
SDI identifies heterogeneous cell populations, by incorporating the relative change in 
fluorescence intensity between two conditions. This makes SDI suited to detect 
heterogeneity between two conditions.  The strength of SDI relies on the assumption that 
different subpopulations within a heterogeneous population exhibit different relations 
between fluorescence intensity and side-scatter (forward-scatter). Based on this 
assumption, SDI uses a linear regression as a computationally efficient way to detect 
differences in these relations.  
SDI requires data from two conditions. However, if heterogeneity is much larger in 
one of the two conditions, SDI is likely to work as well as an approach that looks at a 
single condition at a time (two-peak analysis or k-means). This was true for our setup, 
where most of the meaningful heterogeneous candidates were in SP and not in 
exponential phase. The marginal enrichment analysis showed that most of the enrichment 
of SPV lists was due to the overlap between SDI and SPV lists. 
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3.5 CONCLUSION 
In this paper, we have described a scalable approach for detecting heterogeneous 
populations from high-throughput flow cytometry data. Sample lists obtained from SDI 
measures had superior enrichment compared to lists obtained from visual two-peak 
distributions, average fold change and k-means clustering. The superior enrichment of 
SDI was also supported by our marginal enrichment analysis, where most of the 
enrichment of other approaches was due to the overlap between these lists and SDI list. 
Moreover, gradient-separation followed by visual microscopy, showed that samples 
identified by SDI were highly likely to have differences in GFP localization in high and 
low density cells.   
SDI currently performs linear regression of the fold change in log intensity to side 
scatter. However, for some of the GFP-fusions strains, this linear relationship does not 
hold. Extending SDI to perform a piece-wise linear or non-linear regression is an 
important direction of future research. 
As high throughput flow cytometry becomes more routine with many thousands of 
measurements per minute, approaches that allow rapid characterization of samples will 
become increasingly important.  The SDI approach provides a simple, scalable way to 
identify strain heterogeneity that can identify important biological differences in high 
throughput data that might not otherwise be accessible for evaluation. 
 At this point, we do not completely understand all the factors that govern 
heterogeneity within a cell population. A comprehensive study involving more complex 
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experimental designs over many conditions in concert with approaches like SDI will be 
instrumental in improving our understanding of the cause and benefit of heterogeneous 
cell populations. 
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3.7. SUPPLEMENTAL MATERIALS 
3.7.1 Growth conditions 
Individual strains from the Yeast GFP Collection that were constructed from the 
base strain ATCC 201388: MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 (S288C) (Brachmann, 
Davies et al. 1998) were replicated into 96 well plates containing YPD + A (2% yeast 
extract, 1% peptone, 2% glucose, 0.04 mg/mL adenine, and 50 μg/ml ampicillin; (Rose 
1990) using pin tools.  The plates were covered with Breathe Easy sealing membranes 
(Sigma Aldrich cat #380059) and the strains were cultured at 30°C with aeration either 
overnight (for exponential growth) or for 7 days (for stationary-phase growth). 
3.7.2 High-throughput flow cytometric screening 
Three steps were used to prepare the samples for high throughput screening.  
First, dilution plates were prepared by transferring 90µL of peptide dilution flow buffer 
(30mN HEPES*1/2 Na, 110mM NaCl, 10mM KCl, 1mM MgCl2*6H2O) into each well 
of the 384-well plates (Greiner Bio-one Cat #781280) using the Biomek NX MC 
(Beckman Coulter, Fullerton, CA.) liquid handling robot.  Second, 10µL of each yeast 
strain were transferred from the 96-well growth plates into 3 adjacent wells of the 384-
well dilution plates using the Biomek NXS8 (Beckman Coulter) liquid handling robot. 
This step created a 1:10 dilution and generated three technical replicates for each sample. 
The 4th, 8th, 12th, 16th, 20th, and 24th columns of the dilution plates do not contain samples, 
just buffer alone.  These columns serve as a wash well in between different samples to 
minimize any sample carryover.  Third, the cells were sampled with a HyperCyt® 
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(Edwards, Oprea et al. 2004; Young, Bologa et al. 2005) autosampler controlled by 
HyperSip software and interrogated for GFP fluorescence with a CYAN ADP (Dako 
Cytomation, Ft. Colllins, CO)  flow cytometer using excitation at 488 nm and collection 
of fluorescent emissions with a 530/40 nm filter set. The data were processed using 
IDLQuery software and the median channel fluorescence for each sample was calculated 
and used for subsequent analyses.  
 
3.7.3 Flow dataset  
Approximately 4000 GFP were used in both SPand exponential phase generating 
two datasets.  In each dataset, three technical replicates were generated for every GFP 
where each GFP has approximately 30,000 events.  After applying a filter in which we 
excluded GFP with missing data in either exponential or stationary phase, there were a 
total of 3941 GFP for used in both stationary and exponential datasets. 
 
3.7.4 Reproducibility analysis between biological samples 
In order to make an evaluation on the quality of the data, an additional biological 
sample was generated approximately 4 weeks after the completion of the initial 
experiment, by selecting at random four plates of 96 GFP each.  This additional 
biological sample also had 3 technical replicates.  For both stationary and exponential, 
the two biological samples were joined having a total of 384 GFP, 3 technical replicates 
from the first sample and 3 technical replicates from the second sample.  Each technical 
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replicate contained for each GFP, the average log fluorescence intensity over thousands 
of events, which were then correlated between biological samples.  All the Spearman 
correlation coefficients were over 0.90 and thus we can state the high reproducibility of 
the average fold change. 
 
3.7.5 Reproducibility analysis between technical replicates 
Correlations using slopes from SDI were performed between the three technical 
replicates to show the reproducibility of both side-scatter slopes and forward-scatter 
slopes over the total 3941 GFP. Respective Spearman correlations for slopes from each 
pair of replicates were 0.966(rep1, rep2), 0.971(rep1, rep3) and 0.967(rep2, rep3).  Given 
that all Spearman correlations were above 0.90, we can state the high reproducibility of 
the slope used in SDI.  
 
3.7.6 SDI Algorithm  
Generating the groups: 
1. Sort the exponential- and stationary-phase datasets by side-scatter and define k, 
e.g.,  
k = 50, equally populated groups, defined over the set of all side-scatter events.  
2. Assign all events from exponential- and stationary-phase samples to their 
corresponding groups.  
For every sample j (GFP-strain): 
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3.   Calculate FIsij as the average of log2 of the fluorescent intensity of each event 
from the    SP set, for group j and sample j, and let FIeij be the analogous value for the 
exponential phase set. 
4.   Combine corresponding samples from SP sample j and exponential phase sample 
j into sample-pairs, referred to sample-pair j. 
5.    Three sample-pairs, one per technical replicate.  For every sample-pair, the fold 
change in log-intensity was calculated for each group by taking the difference in 
average log intensity between them.   
6. Calculate ∆FCij = FIsij – FIeij, the average fold change for group j from sample-
pair j. 
7. For every sample-pair i, select groups with both number of events ≥50 in SP 
sample i and number of events ≥ 50 in exponential phase sample i.  In the end, 
each sample-pair i will have a total of k’iI selected groups, where k’i ≤  k. 
8. Calculate the average log2 in side-scatter for each corresponding selected groups, 
denoted as xi1, xi2,…, xik’.  Let array X denote the set containing these values. 
9. Let ∆FCi1, ∆FCi2,…, ∆FCik’ be the array Y of fold-change values for the selected 
groups for sample j. 
10. Regress Y on X and generate slopei, the slope for sample j. 
Combining the sample-pairs for the three replicates from each GFP-strain i: 
11. Three slopes are generated, one for each j replicate sample-pair.   
12. Calculate the median of the slopes over all three sample-pairs mij. 
13.  An approximate z-statistic is obtained for every sample by subtracting each mij by 
its mean over 3941 samples and dividing the difference by the standard deviation 
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of mij over all 3941 samples.  This z-statistic is the numerical value for GFP-strain 
i which is called SDIi.. 
 
3.7.7 GO Term Finder settings 
The main settings used for GO term finder are: ORF’s only, no ‘dubious’ 
categorized genes, ‘manually annotated’ with a background set of genes being the set of 
3941 ORF’s corresponding to their respective GFP (http://db.yeastgenome.org/cgi-
bin/GO/goTermFinder.pl).  When calculating the p-value the option ‘no Bonferroni 
adjustment’ was chosen. Ontology was set to ‘process’ and the cut-off level for the 
category p-values was 0.01(default value). 
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Chapter 4 - CRAM 
 
4.0 ABSTRACT  
 
Background:  With the advent of genomics, there has been a rapid increase in the use of 
two and one-color microarrays, used to measure mRNA abundance for the entire genome.  
Variability in microarray analysis undermines its utility in identifying the entire subset of 
differentially expressed mRNAs.  Recent microarray studies have shown that, although it 
is assumed that variances are constant for every hybridized spot within a microarray, 
variances may differ for each biological sample analyzed (Ritchie, Diyagama et al. 2006).   
Another common assumption is that log-intensity values for any given gene have a 
Normal distribution.  For many datasets, both assumptions have been shown to be 
incorrect, resulting in distortions in the significance when testing for differential 
expression of each gene (Bar-Even, Paulsson et al. 2006; Wentzell, Karakach et al. 2006).   
Approach: To overcome the limitations of existing approaches in identifying significant, 
differentially expressed genes, we have developed a novel unsupervised statistical 
approach called Calibration Regression Analysis of Microarrays (CRAM) that uses a 
combination of empirical Bayes and regression calibration.  The main novelty of our 
Osorio Meirelles1, Sushmita Roy2 and Margaret Werner-Washburne1 
Calibration Regression Analysis of Microarrays
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approach is the modeling of gene expression variances as a function of the log-intensity 
within each sample.  Another version was later developed CRAM-GS in which the 
association between genes is captured using an adjusted gene correlation measure. 
Results:  CRAM was compared to four existing approaches for identifying differentially 
expressed genes.  Performance was based on the ability to identify co-regulated genes in 
the same Gene Ontology process.  CRAM exhibited a marginal improvement in  GO 
process enrichment compared with the other approaches.  To the original datasets, three 
more were included in which the later version CRAM-GS, showed a significant 
improvement compared to CRAM, suggesting a major additional benefit of incorporating 
gene correlations into the model.  All versions of CRAM were two orders of magnitude 
faster than the existing approaches. Overall, CRAM provides an adaptive, 
computationally efficient approach for accurate identification of differentially expressed 
genes. 
Keywords — Empirical Bayes, microarrays, regression, measurement error, 
calibration. 
4.1 INTRODUCTION 
  Accurate identification of differentially expressed genes, detected as changes in 
mRNA abundance, is crucial for extracting biological relevance from microarray data.  
Methods for identification of differentially expressed genes typically use some type of t-
statistic, requiring the estimation of both expected log-intensity values across samples for 
expression of every gene, and the variance of the expected log-intensity for the same 
genes.  
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     In this paper, we define gene-expression variance for one microarray spot as a 
product of sample-specific variance and gene-specific variance (Ritchie, Diyagama et al. 
2006).      Sample-specific variance results from technical or measurement error.  Gene-
specific variance is described as the variance contribution attributed to biological 
expression of each gene or the deviations from the expected log-intensity across samples.   
Different methods make different assumptions for estimating the gene-specific 
variance and sample-specific variance.  Gene-specific variance is commonly estimated 
using log ratios for each gene, across all samples.    However, when datasets have a small 
number of arrays, gene-specific variance is often underestimated, resulting in inflated t-
statistics (Smith 2004). 
Many approaches improving gene-specific variance estimators have been developed 
to address the problem of distorted t-statistics (Efron B 2001; Tusher, Tibshirani et al. 
2001; Lonnstedt and Speed 2002; Broberg 2003; Smith 2004; Kristiansson, Sjogren et al. 
2005; Kristiansson, Sjogren et al. 2006; Ritchie, Diyagama et al. 2006; Astrand, Mostad 
et al. 2007; Sjogren, Kristiansson et al. 2007; Astrand, Mostad et al. 2008).   These 
approaches assume that the expected expression values have a Normal distribution.  
However, in microarray data from heterogeneous biological samples, where each sample 
corresponds to a different subject, this is unlikely to be true.  In heterogeneous samples, 
the Normality assumption is typically violated because of large variations between 
samples, producing inaccurate gene-specific variance estimates, and thus, distortions in t-
statistics estimates.   
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 Sample-specific variance, although usually distinct for each sample, is usually 
modeled by assuming it is constant for every gene within each sample.  Unfortunately, 
sample-specific variance is often dependent on the intensity level of each gene (Bar-
Even, Paulsson et al. 2006; Wentzell, Karakach et al. 2006).  To address the limitations of 
both sample-specific variance and gene-specific variance assumptions, we have 
developed a novel statistical algorithm. Calibration Regression Analysis of Microarrays 
(CRAM) models both sample- and gene-specific variance based on analysis of the data, 
by combining empirical Bayes (Baldi and Long 2001; Lonnstedt and Speed 2002; Smith 
2004; Kristiansson, Sjogren et al. 2005; Kristiansson, Sjogren et al. 2006; Sartor, 
Tomlinson et al. 2006; Astrand, Mostad et al. 2007; Sjogren A 2007; Astrand, Mostad et 
al. 2008) and regression calibration (Spiegelman, McDermott et al. 1997; Schneewei B 
2005) to accurately identify differentially expressed genes.   
CRAM was compared with four existing approaches:            Locally moderated 
weighted t-statistics (LMW) (Astrand, Mostad et al. 2008), Weighted moderated t-
statistic (WAME) (Smith 2004; Kristiansson, Sjogren et al. 2005; Kristiansson, Sjogren 
et al. 2006; Astrand, Mostad et al. 2007; Sjogren A 2007), fold change (FC), and 
ordinary t-statistic (t), on four yeast microarray datasets (Aragon, Rodriguez et al. 2008).   
Performance was measured using Gene Ontology (GO) process 
enrichment(GeneOntology ; GOTermFinder).  CRAM showed a marginal enrichment 
improvement compared to other approaches.  Additionally, CRAM is highly 
computationally efficient compared with other methods, scoring a dataset of 88 samples 
in less than one second as compared with several minutes for other approaches. 
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 In addition to capturing associations between microarray samples, the more recent 
CRAM-GS captures associations between genes.  The underlying assumption is that since 
every gene belongs to a pathway containing one or more genes, a differentially expressed 
gene should have a strong level of association with at least some other gene.   Similarly to 
correlating samples, a gene highly correlated with another gene is an indication of 
confidence in the expression values of that gene.  For this reason, the quantification of 
gene correlations will prove to be a significant improvement over CRAM.   CRAM-GC is 
also computationally very efficient, making it applicable to large microarray datasets. 
 
4.2 RELATED WORK 
A basic model for identifying differentially expressed genes estimates the expected 
log-intensity by calculating the average of log-intensity across all samples.  Similarly, 
gene-specific variance is estimated by calculating the variance of log-intensity values 
across all samples, generating a standard t-statistic for every gene.  This model often 
underestimates variances in log intensity when the number of samples is small, leading to 
overestimated t-statistics.  To address the issue of inflated t-statistics, many methods have 
been developed in recent years. 
Penalized t-statistics type approaches, add a constant to the gene standard deviation 
across samples, whereas the posterior odds t-statistic, also known as B-statistics, adds a 
constant to the gene expression variance, providing a better solution (Efron B 2001; 
Tusher, Tibshirani et al. 2001; Lonnstedt and Speed 2002; Broberg 2003).  The posterior 
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odds t-statistic method was later extended into the moderated t-statistic (Smith 2004).  
However, moderated t-statistics does not account for sample-specific variance.  
Moderated t-statistic was extended to Linear models for microarray data, 
LIMMA, with the assumption that each array had a constant but distinct sample-specific 
variance (Ritchie, Diyagama et al. 2006).  LIMMA is also a software application part of 
the Bioconductor Projects web page (LIMMA). LIMMA however, assumes 
measurements from biological samples are independent, which is not true for many 
datasets (Kristiansson, Sjogren et al. 2005).  
Weighted moderated t-statistic (WAME), overcomes the measurement 
independence assumption by introducing a correlation structure between samples.  
Locally moderated weighted t-statistic (LMW), also part of the PLW software 
application, is an improved version of WAME that incorporates the modeling of gene-
specific variance as a function of the expected intensity level of each gene (PLW-Astrand 
2008).   
All three approaches, LIMMA, WAME and LMW use some form of moderated 
t-statistic based on the estimation of gene expression variance using an independence 
assumption between gene-specific variance and sample-specific variance.  With this 
independence assumption, gene expression variance can be defined as a product of gene-
specific variance and sample-specific variance. Similarly, our method estimates gene 
expression variance under the same independence assumption, however, we allow the 
sample-specific variance to vary within each sample as a function of intensity levels for 
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every gene in the sample.  The independence assumption between gene-specific variance 
and sample-specific variance is also used in    CRAM-GS. 
 
4.3 METHODS 
4.3.1 Datasets  
A total of four yeast cDNA microarray datasets were used to validate our approach 
(Aragon, Rodriguez et al. 2008).  Arrays are assumed to have undergone a standard 
microarray normalization process, followed by natural logarithm transformation on all 
expression values, generating a log-intensity value for every gene in every array.  Each 
dataset measures gene expression change from two yeast cell populations, quiescent and 
non-quiescent, separated from stationary phase cultures using density centrifugation. 
The datasets used are the same as used in chapter 2, with the main difference being 
that the datasets described and referred to as 1 to 4, correspond to the datasets in chapter 
2 from 2 to 5. Dataset 1 has 80 microarrays from the quiescent population and 80 from 
non-quiescent, where each microarray measures the gene expression profile of a single 
yeast deletion mutant.  Dataset 2 is similar to dataset 1 with 176 microarrays from 88 
mutants. Datasets 3 and 4 have 32 and 20 microarrays respectively, corresponding to 16 
auxotrophic parental (BY4742) strains and 10 wild type (S288C) strains.   
Datasets 1 and 2 are said to be heterogeneous since they have very dissimilar 
samples due to the genetic differences, resulting in high biological variability.  Datasets 3 
and 4 are said to be homogeneous datasets in which samples are biological replicates and 
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therefore are expected to have lower biological variability than datasets 1 and 2. We 
excluded genes with >80% missing values in any dataset producing a total of 5649 genes 
in all datasets.  
For each biological sample we subtracted the log intensity measurements in the non-
quiescent microarray from the quiescent microarray. Next, this difference in log-intensity 
was adjusted by subtracting the mean log-intensity difference over all genes, such that the 
mean of log-intensity difference was equal to zero.  We will refer to differences in log-
intensity as delta log-intensity throughout this article. 
 
4.3.2 Method Overview 
Differentially expressed genes are typically identified using t-statistics, which 
require the estimation of the variance of every gene.  Gene expression variance is a 
product of two entities: gene-specific variance and sample-specific variance (Ritchie, 
Diyagama et al. 2006).  Gene-specific variance is defined as the variance contribution 
attributed to each individual gene, and sample-specific variance is defined as the variance 
contribution of each individual sample.  
Calibration Regression Analysis of Microarrays (CRAM) is a novel approach for 
identifying differentially expressed genes that is based on three themes: 
 (a) gene-specific variance is treated as a weighted average between the variance 
estimate of a gene and the average of these variance estimates over all genes,  
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(b) sample contribution of each to the gene expression variance is weighted 
according to the quality of each sample, and  
(c) sample-specific variance is not constant, but rather depends on the intensity level 
of the genes within the sample.    
CRAM first uses a linear regression model to predict a sample using the remaining 
samples. Next, the predicted sample is regressed using the original sample where a slope 
is generated.  Using an Empirical Bayes approach, slopes are transformed into weight 
parameters, inversely proportional to the sample-specific variances. We extend this 
weight estimating procedure to gene subsets within each sample, increasing the precision 
of the weights and therefore the accuracy of expected delta log-intensity. 
 
4.3.2.1 Notation  
 Let k represent the number of biological samples in a dataset and n the number of 
genes.  
Denote Xj  = {x1j, x2j, ... , xnj}  as the set of delta log-intensity values for every gene i in 
sample j.  A dataset with k samples will be represented as the set {X1, X2,…., Xk.}. 
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4.3.3 Linear model 
Let xij, the observed ∆log-intensity value for gene i in sample j be written as  
                                xij   = τi  + eij ,           for i = 1,2,…, n  and j = 1,2,…,k                     (4.1) 
where τi  is N(µi , σi2 )-distributed random variable,  representing the unknown measure of 
the expected  ∆ log-intensity for gene i,  µi is a known prior expected ∆ log-intensity and 
σi2 is the unknown variance of ∆ log-intensity for gene i.  The random variable eij is an 
unknown measurement error for gene i in sample j, assumed to be N(0, σi2/wj)-
distributed, which variance is proportional to the variance of τi  by a  factor equal to 
1/wj.   We also assume that τ1 , τ2 , …, τn  are independent, that the eij are independent for 
all i and j, and that the τi  and eij are independent for all i and j.   Thus, since the sum of 
normally distributed random variables is itself normally distributed, we see that the 
random variable xij is N(µi ,σi2 + σi2/wj)-distributed, or equivalently,                             
N(µi ,σi2 (1+ wj )/wj)-distributed.  
 The identification of differentially expressed genes requires us to perform a 
hypothesis test for every gene i:     
               H0:  τi  = 0 
vs. 
            H1:  τi  ≠  0 
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If H1 is true, gene i is said to be differentially expressed, and if H0 is true gene i is said 
not to be differentially expressed.   For example, in datasets 1 to 4, if H1 is true, a gene i 
is said to be differentially expressed in relation to Q vs. NQ.  Similarly, the same idea 
applies to any differences between two conditions.  Summarizing, we assume random 
variables τi and eij to have the prior distributions  
                τi ~ N(µi,  σi2 )    and    eij  ~ N(0,   σi2/ wj  )  ,                                   (4.2) 
where τi and eij are mutually independent, eij is independent for gene i and sample j, σi2  
0≥   is the unknown variance of τi , µi is the known prior expectation for τi , and wj > 0 is 
an unknown positive parameter for sample j.  The parameter σi
2 is defined as the gene-
specific variance, whereas the sample-specific variance is defined as 1/ wj.   Thus, the 
variance of eij is σi2/ wj, the product of gene-specific and sample-specific variances.  In 
addition, the set of unknown expected ∆ log-intensity values τ1 , τ2 , …, τn  are assumed to 
be independent, which is equivalent to assuming uncorrelated genes or more formally, 
that the knowledge of parameters τi’, σi’
2  for any gene i’ does not influence (or change) 
the conditional distribution of τi for gene i. Although this is a simplistic assumption since 
it is known that many genes are often correlated, this assumption is still often used in 
most of the current models.  We now need to estimate the gene parameters τi, σi
2, and the 
sample parameters w1, w2,…, wk , which we describe in the next subsection.    
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4.3.3.1 Estimating τi  
From (4.1) and (4.2):          
                          P(xij | τi = λi)   ~  N(λi , σi2/wj).                                             (4.3)  
   The posterior distribution τi | wj , xij  is also a Normal distribution  
   P(τi | xij)   ~ N(  (µi  + wj xij )/(1+ wj) , σi2 /(1+ wj ) ).                          (4.4) 
For proof please see supplemental materials 4.7.2.  
From the expression above, if we do not know the value for the prior µi, we set it equal to 
zero, which is the mean of the normalized expression values xij over sample j.  When wj is 
equal to zero, the posterior variance is equal to σi
2 (the prior variance of τi) implying that 
the value xij has no useful information since the posterior mean is shrunk to µi (the prior 
expectation of τi).  When wj becomes large, the posterior variance becomes close to zero, 
wj/(1+ wj) becomes closer to one and thus the posterior mean becomes close to xij, 
indicating a large confidence in the value xij as an estimate of τi  and thus, the influence of 
µi in estimating τi becomes negligible.  So when wj is small (large sample-specific 
variance), there is low confidence in the observed xij values in sample j whereas when wj 
is large, there is high confidence in these values.  Denoting  W = (w1, w2, … ,wk) and Xi 
= (xi1 , xi2, … , xik), after observing all samples and assuming independence among 
samples Xj, we generalize the posterior distribution  
P(τi | Xi) which has a Normal distribution with mean ui ,where   
96 
 
                    ui  = E(τi | Xi)  = (µi  + ∑
=
k
j 1
  wj xij )/ (1+∑
=
k
j 1
 wj )                    (4.5)                        
is also the maximum likelihood estimator of τi.   Furthermore, µi parameters can be very 
useful if they were obtained as the output (a measure of expected gene expression) from a 
previous experiment performed under very similar conditions, which could potentially 
largely improve the precision of the current model.  Considering that in our datasets we 
do not know the prior µi parameters, we set all of them equal to zero, in all datasets.   
However, we chose to keep the µi parameters in most equations, in order to describe the 
most general case.  Setting all µi equal to zero, equation (4.5) simplifies to 
                                        ui  = E(τi | Xi)  = (∑
=
k
j 1
  wj xij )/ (1+∑
=
k
j 1
 wj ) . 
The conditional variance of τi |Xi  is equal to  
                                          Var(τi | Xi  ) =   σi2 / (1+∑
=
k
j 1
 wj).                             (4.6)                        
See supplemental materials 4.7.3 for more details. 
4.3.3.2 Estimating wj   
To estimate the parameter wj we use a linear regression to estimate sample Xj by 
regressing it on the remaining samples, generating a sample vector Yj of predicted values 
of Xj.   Next, we use an Empirical Bayes approach and equate the posterior expectation 
E[τi | Xj ] = Yj .    By minimizing the sum  
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∑
=
n
i 1
 (E[τi | wj , xij ] - yij)2 = ∑
=
n
i 1
 (  (µi  + ∑
=
k
j 1
  wj xij )/ (1+∑
=
k
j 1
 wj ) - yij  )2 , we 
find the optimal weight parameter wj, given by: 
                  wj =( ∑
=
n
i 1
  (yij - µi )( xij - µi ) ) / ( ∑
=
n
i 1
  (xij - yij )( xij - µi ))      (4.7) 
For the proof see supplemental materials in 4.7.4. 
 
4.3.3.3 Testing for differential expression 
To test for differential expression we calculate the variance of the posterior expectation 
ui: 
        Var(ui)     =    σi2 ∑
=
k
j 1
  wj(1+ wj)/ (1+∑
=
k
j 1
 wj )2 .                                                           (4.8) 
For more details on the proof see supplemental materials. 
Dividing the expectation ui in (4.6) by the square root of (4.8) we get a z-statistic for 
gene i,  
        ai    =  (µi  + ∑
=
k
j 1
 wj xij  )/( σi (∑
=
k
j 1
 wj (1+wj ))1/2) ~ N(0,1).                 (4.9) 
 
4.3.4 CRAM model: sample-specific variance with different contribution per gene 
98 
 
CRAM allows genes with different intensity values to have different weights. The ∆ 
log-intensity values xij in sample j, are first categorized into smaller groups.  In order to 
obtain more stable weight estimates, genes are categorized into three groups.   Genes 
within a sample can be categorized into any number of groups but the influence of 
outliers on the weight parameters increases with the number of groups.   Empirical 
analysis with different number of groups showed that three groups were optimal in our 
setup. 
A sample Xj  is sorted such that the highest one third of its ∆ log-intensity values are 
assigned to group 1, the middle one third are assigned to group 2 and the lowest one third  
are assigned to group 3.  Similar to the procedure in section 4.3.3, genes in each group g 
from sample j are regressed with their corresponding genes in other samples and a weight 
Wgj for group g is estimated.  After estimating Wgj for each group, genes in sample j are 
assigned a weight from the group to which they belong wij =  Wgj.  This procedure is 
repeated for the other samples where all weights are estimated.   Although modeling the 
weight for each group in a sample, implies that weights and expected ∆ log-intensity are 
not independent, we assume a local-independence in which the weight assigned to a 
group is independent from the ∆ log-intensity values in that group. 
 
4.3.4.1 Estimating the gene-specific variance σi
2 
The first step to estimate the gene-specific variance σi2 is to calculate si2, the pre-
moderated gene-specific variance across samples given by: 
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si2 = ∑
=
k
j 1
 wij(xij-ui)2/ ( (∑
=
k
j 1
 wij)2  - ∑
=
k
j 1
 wij2) / ∑
=
k
j 1
 wij )   
 Next, we calculate V2, the average of si2 over n genes,  
       V2 = ∑
=
n
i 1
si2 / n 
A gene-specific variance moderating factor α, a parameter between zero and one is used 
such that the estimate for the moderated variance is given by: 
i = αsi2 + (1- α) V2                                             (4.10) 
For more details in how to estimate α, please see supplemental materials. 
 
 
 
4.3.4.2 Estimating the CRAM z-statistic 
Extending (4.9) to different weights within samples, a CRAM z-statistic is 
estimated for gene i, under the local-independence assumption as introduced in 4.3.4,   
                   i = (µi  + ∑
=
k
j 1
 wij xij  )/(  i (∑
=
k
j 1
 wij (1+wij ))1/2)                        (4.11) 
The statistic above is only a standard Normal distribution in ideal situations, when all 
underlying assumptions are true.   An additional transformation is often required to 
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generate more accurate p-values as suggested by (Eaves, Wicker et al. 2002).   For more 
accurate p-values, we calculate a standardized transformation generating the CRAM z-
statistic, given by: 
zi  = ( i  - average( 1, 2, … , n ) ) / stdev( 1, 2, … , n )  
and the two tail p-value is given by   
                                                         p-value = 2 Φ (-|zi|)                                   (4.12) 
where Φ is the standard normal cumulative distribution function. 
 
4.3.5 Comparison of CRAM against other approaches 
We compare CRAM against all other methods using the biological significance of 
gene lists identified by each approach. To measure the biological significance of gene 
lists, we use enrichment of Gene Ontology (GO) biological process categories 
(GeneOntology ; GOTermFinder).  The primary assumption is that a more accurate gene 
list will have on average, more significant GO categories than a less accurate gene list. 
We used an iterative approach to assess biological significance of gene lists from each 
approach. In each iteration a subset of k’ samples (k’ = 4 in this paper) is randomly 
selected and submitted to each method, which produces a candidate list of differentially 
expressed genes of a pre-specified size m.  Gene lists are generated by sorting in 
descending order by the measure of differential expression of each approach (z-statistic in 
CRAM).  Next the top m genes are selected into a gene list. We consider gene lists of 
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sizes m = 200, 400 and 800 genes.  A total of 1000 iterations are performed for each 
dataset and for each gene list size.   
For each gene list, a p-value is obtained for each GO category using an algorithm 
based on GO Term Finder (Boyle 2004).   The most significant GO category (smallest p-
value) is selected and its corresponding p-value is stored for each approach and for each 
gene list size.  After all iterations are performed, the average of the -log(p-value) for each 
approach and each gene list size is computed. The average -log(p-value) over all 
iterations is used as the measure of biological significance.  
 
4.3.6 Other Versions of CRAM 
4.3.6.1 CRAM-binary 
 This is a robust version of CRAM and was developed to handle datasets with a high 
incidence of outliers.   Instead of using its original values, all samples Xj are ranked and 
categorized as a dichotomous variable.   For a detailed description of the algorithm, 
please see supplemental materials. 
 
4.3.6.2 CRAM expectation maximization (CRAM-EM) 
 This is the fastest version of CRAM.   It replaces the regression step as in 4.3.3.2 by 
assigning initial weights w1, w2,…, wk = 1.   In this version, Xj is also estimated using 
the remaining samples but instead of using a regression, Xj is estimated using a iterative 
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procedure where a weighted average is used.  Then Yj , which is the estimate of Xj  is 
given by 
Yj  = ( ∑
=≠
k
jl 1
wlXj  ) /  ( ∑
=≠
k
jl 1
wl ) where yij  = ( ∑
=≠
k
jl 1
wlxij  ) /  ( ∑
=≠
k
jl 1
wl ) .   
For a detailed description of the algorithm, please see supplemental materials in 4.7.4. 
 
4.3.6.3 CRAM gene correlation (CRAM-GC) 
 In addition to capturing associations between microarray samples, this version also 
captures associations between genes.  The underlying assumption is that since every gene 
belongs to the same pathway of another gene, then a differentially expressed gene should 
have a strong level of association with at least some other gene.   Similarly to correlating 
samples, a gene highly correlated with another gene is an indication of confidence in the 
expression values of that gene.  For this reason, the quantification of gene correlations 
will prove to be a significant improvement over all previous versions of CRAM.   
CRAM-GC is also computationally very efficient, making it applicable to large 
microarray datasets. 
 
  4.3.6.3.1 Additional Datasets:  
  To test the CRAM-GC approach, we used the 4 datasets described in the 
beginning   of this chapter, and added 3 additional datasets (Gasch, Spellman et al. 
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2000; Tu, Kudlicki et al. 2005; Hu, Killion et al. 2007) , named respectively datasets 
5, 6 and 7 (Table 1). 
 
 
 
 
Table 1 – Description of the three additional datasets used to measure the performance of 
CRAM-GC. 
DATASET  Description  ARRAY TYPE 
# 
microarrays
5  Yeast mutant strains  Two colors non‐paired  174 
6  Yeast CEN.PK strain 
One color non‐paired  
time course   36 
7 
 Yeast mutant strains (transcription 
factor deletion)  Two colors non‐paired  269 
 
All of the additional datasets were non-paired, meaning that each sample corresponds to a 
specific microarray.  Dataset 5 with 174 cDNA microarrays (two colors) is a dataset in 
which responses were measured for many different stresses.  Dataset 6 with 36 
microarrays is an Affymetrix (Affymetrix) type microarray (one color) with a time course 
covering three complete cell cycles.  In dataset 7 with 269 cDNA microarrays, each 
microarray corresponds to a transcription factor deletion (263 non-essential and 6 
essential).  Dataset 5 and 7 can be considered heterogeneous datasets, whereas dataset 6 
is not clearly defined, given that each sample is a biological replicate but at a different 
time point, and therefore has higher heterogeneity than a typical biological replicate 
experiment, but lower heterogeneity than datasets 5 and 7.  An overall description of the 
CRAM-GC version is presented next, followed by the algorithm. 
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 4.3.6.3.2 CRAM-GC linear model:  
    Let xij  = τij  + eij , where eij ~ N(0, σi2/wij), and xij is the gene expression (say 
log-intensity or ∆log-intensity) for gene i and sample j, wij  > 0 is a weight (or 
precision) parameter of gene i and sample j, for a total of k samples and n genes and 
τij is an unknown random variable for gene i and sample j, with distribution         
N(µij , σi2), where µij is a known prior estimate of τij for gene i and sample j. 
 
  4.3.6.3.3 Posterior expectation 
        As a result, the posterior expectation E[τij | xij] is a Gaussian distribution with 
mean equal to (µij + wij xij )/(1+ wij)  and variance equal to σi2 /(1+ wij).   
 
 
  4.3.6.3.4 Homogeneous sample weight assumption 
 In this version, we assume that the weight for every sample is constant within 
each sample.  A non-constant array (sample) weight can also be used, but since only a 
minor improvement in GO enrichment was observed, we will use this assumption for 
simplicity.  In this version of CRAM, the sample weight for sample j is denoted as aj. 
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    4.3.6.3.5 Sample-gene weight independence assumption 
       The cell (gene-sample combination) weight wij can be written as wij =  aj gi, 
where gi is defined as the gene weight for gene i, under the assumption that the 
sample weight aj is independent from the gene weight gi. 
 
    4.3.6.3.6 Estimating sample weights aj.   
 In order to increase computational performance with a very minor loss in 
precision, we estimate the sample weights based on the highest correlated sample with 
each sample.  We first generate a Spearman correlation matrix for all k samples and select 
for each sample j the maximum absolute value of the correlation coefficient over all 
remaining k-1 samples.  Next, we let ρj be the maximum correlation coefficient of 
sample Xj and let Xj’ be the sample with maximum correlation with Xj.    Next we generate 
a predictive value Yj  by performing the regression Yj = c Xj’, where c minimizes the loss 
function L for sample j, given by sum of the squared residuals  L = ∑
=
n
i 1
  (xij - c xij’)2.   
Similar to 4.3.3.2, if we let µj be the vector of prior parameters for sample j denoted by 
(µ1j, µ2j,…, µnj) and letting Tj = {τ1j,τ2j,…,τnj} be the vector of unknown expectations 
for sample j the weight aj is estimated by equating the posterior expectation E[Tj | Xj] = 
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(µj + Xj aj)/(1+ aj) = Yj , where aj > 0 is the weight parameter for sample j, we 
estimate aj that minimizes the sum  ∑
=
n
i 1
  (E[Tj | Xj] - Yj )2 , and similar to (4.7) we get  
                                 aj =( ∑
=
n
i 1
  (yij - µij )( xij - µi ) ) / ( ∑
=
n
i 1
  (xij - yij )( xij - µi )).      
4.3.6.3.7 Estimating gene weights gi.  
         The next step is to generate a Spearman correlated matrix for all n genes and 
select   for each gene i the maximum absolute value of the correlation coefficient over 
all remaining n -1 genes and call ρi the corresponding correlation coefficient.   In 
datasets in which the number of samples k are small, given that the number of gene n 
is large, a maximum absolute correlation can be a high number just by chance, that is, 
under a random scenario.   
    For example, under a random scenario in which expression values are permuted 
within each gene, the maximum correlation between genes can be highly inflated by 
chance, leading to the expectation E[ρi] > 0 but most of all, E[ρi] can become close 
to one.  In order to correct for optimistic gene correlations for datasets of all sizes, we 
need to deflate each ρi, generating an adjusted ρi which we will call ρi
’.   
The basis of this approach is to test if |ρi| is greater than |ρiR| the maximum 
correlation between genes in a random scenario, obtain a p-value, and then use the p-
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value to deflate |ρi|.  We should keep in mind that |ρiR| is a random variable, whereas 
|ρi| is the observed maximum correlation between gene i and the remaining genes. 
   
4.3.6.3.8 Fisher’s transformation of Spearman’s correlation coefficient 
 
Applying Fisher’s transformation to ρi, which we will call f(ρi), we get  
zi = f(ρi) = 0.5(k-3)1/2ln( (1+|ρi| )/( 1- |ρi| ) ) 
where zi is approximately the absolute value of a N(0,1) under a random scenario.   
Let α be the level of significance such that  
α = 1/n      and       z0i = Φ-1(1-α), 
where Φ-1 represents the inverse of the Normal cumulative distribution function and z0i 
represents the standardized z-statistic corresponding to the maximum correlation under 
a random scenario with significance level equal to α.   Let f--1 be the inverse function 
of the Fisher transformation such that  
f--1(z0i) = (exp{2z0i/(k-3)1/2} – 1)/(exp{2z0i/(k-3)1/2} + 1), 
and 
                                 z1i = z0i + f--1(z0i) (k-3)1/2/2(k-1) 
     where z1i is the mean of the transformed maximum correlation coefficients 
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    (mean of f(|ρiR|) ), generated under the random scenario.  Finally let zi’= zi – z1i, 
which is the distance between zi (the transformed |ρi|) and z1i (the transformed |ρiR|).    
Let R be the random variable N(z1i , 1). Then, the likelihood of observing zi in R,  
is the density of the conditional distribution  P( R | zi) which is N(zi’,1).   In order to 
avoid negative values for zi’, we set the constraint that zi’= 0, if zi’ < 0.   By using the 
inverse Fisher transformation on zi’, we get |ρi’| = f--1(zi’), where |ρi’| is the adjusted value 
for |ρi|, the absolute value of the observed correlation coefficient.  After generating the 
adjusted correlation |ρi’| for every gene i, we find the gene weight following similar steps 
to estimating the sample weights aj.  We regress Xi = {xi1, xi2, …,xik} with the gene with 
the highest correlation                          Xi’ = {xi1’, xi2’, …,xik’}  such that Xi = ciXi’, 
where the slope ci minimizes the sum of the squared residuals.  Without any adjustment, 
ci is given by ρi (σx/ σx’), thus the adjusted ci is given by ρi’ (σx/ σx’), which is equal to 
the original ci multiplied by the shrinking factor |ρi’|/|ρi| and thus each yij from (4.7) can 
be written as ci|ρi’|/|ρi| xij, thus, the weight for gene i is given by 
gi = ( ∑
=
k
j 1
  (ci|ρi’|/|ρi| xij - µij )( xij - µi ) ) / ( ∑
=
k
j 1
  (xij - ci|ρi’|/|ρi| xij )( xij - µi )). 
Comment:  the adjustment for the sample correlations (estimating aj) was not used 
since the number of samples (k = 300) is small compared to the number of genes n   
(≈ 6000 for yeast) and therefore it is not necessary to adjust for sample correlation 
coefficients.  In summary, the main reasons for not adjusting the sample correlation 
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coefficients is (a) there are a much smaller number of correlations between samples in 
which the maximum is selected, as compared to correlating genes and (b) the sample 
vectors are much larger than the gene vectors (n vs. k), making the sample correlation 
coefficients much more stable. 
 
  4.3.6.3.9 Expected log-intensity of a gene-sample combination. 
   Since wij = aj gi , after all sample weights and gene weights are estimated, we have  
the expected value of the posterior  
                                        E[τij | xij]  = (µij + xij wij )/(1+ wij).                               (4.13) 
      So if either aj = 0 or gi = 0, this would imply wij =  0, indicating we have no 
confidence in our value xij and therefore E[τij | , xij ] = µij, the prior expectation for gene 
i. 
 
4.4 RESULTS 
4.4.1 Normality assumption 
 We first assess the extent to which each dataset satisfies the normality assumption.  
For all four datasets, a standardized expected ∆ log-intensity value was generated for 
every gene by using equation (4.9) which assumes weights are constant within each 
sample.   Next a histogram of the standardized values was plotted for each dataset (Fig. 
1).    In addition, a Kolmogorov-Smirnoff test for normality was used.  Dataset 1 had a p-
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value < E-300, dataset 2 had a p-value equal to 7.6E-242, dataset 3 had a p-value equal to 
1.7E-04 and dataset 4 had a p-value equal to 3.9E-128.  These p-values also suggest data 
in all four datasets are not normally distributed, although in dataset 3 this can be 
attributed to the left tail, since the right tail looks close to Normal. 
 
 
 
 
 
 
Figure 1 – Histogram of standardized expected ∆ log-intensity (ui/stdev(ui)) for each 
of the four datasets.  Histograms for datasets 1 and 2 are very different from the 
continuous line (standard Normal distribution).  The distribution of standardized values 
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in dataset 3 looks Normal, whereas in dataset 4 it has clearly a thicker tail than a 
Normal distribution and its histogram is skewed to the right.  The result of long tails in 
datasets 1 and 2 and to a lesser extent in dataset 4, suggest inflated t-statistics, 
originating from the underestimation of gene-specific variances.  Also, heavy tails on 
datasets 1 and 2 indicate high biological heterogeneity between samples.    
 
4.4.2 Enrichment measures – CRAM  
We compared the enrichment of CRAM to four other approaches of identifying 
differentially expressed genes. These approaches were two state of the art algorithms for 
measuring differential expression, locally moderated t-statistic (LMW), weighted 
moderated t-statistic (WAME) and two general algorithms fold change (FC) and t-
statistic (t). We also compare against an approach, RANDOM, which generates random 
gene lists as a baseline for comparison.    
We first considered up-regulated genes that were high in the quiescent population 
compared to non-quiescent. CRAM had the highest enrichment for gene list sizes 400 and 
800 in dataset 1 (Table 2) and had equal performance, compared to WAME for gene list 
size 200.    
Table 2 – Enrichment (average -log p-value) for gene lists of different size for each 
method.  Highest enrichment for each sample size in bold.  Standard errors are 
approximately 0.25 for all methods excluding RANDOM with SE = 0.04.  If the highest 
and second highest enrichment are not significantly different, the two enrichment values 
are made bold.   
DATASET 1 - GO ENRICHMENT 1000 simulations 
list size CRAM WAME LMW FC t RANDOM 
200 24.84 24.89 22.78 23.3 10.91 6.93 
400 37.97 36.97 31.68 31.89 12.52 7.12 
800 32.28 31.00 31.23 28.97 16.04 6.88 
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Dataset 2 showed CRAM and WAME as the most enriched and equivalent for all sample 
sizes (Table 3).  
 
 
Table 3 – Enrichment (average -log p-value) for gene lists of different size for each 
method.  Highest enrichment   for each sample size in bold.  Standard errors are 
approximately 0.25 for all methods excluding RANDOM with SE = 0.04.  If the highest 
and second highest enrichment are not significantly different, the two enrichment values 
are made bold.   
DATASET 2 - GO ENRICHMENT 1000 simulations 
list size CRAM WAME LMW FC t RANDOM 
200 24.11 24.22 23.85 23.49 15.15 6.92 
400 103.71 103.91 85.24 84.5 36.25 6.87 
800 84.81 84.65 83.71 76.8 44.95 6.96 
In dataset 3, CRAM had the highest enrichment for all gene list sizes (Table 4).   
 
 
Table 4 – Enrichment (average -log p-value) for gene lists of different size for each 
method.  Highest enrichment for each sample size in bold.  Standard errors are 
approximately 0.25 for all methods excluding RANDOM with SE = 0.04.  If the highest 
and second highest enrichment are not significantly different, the two enrichment values 
are made bold.   
DATASET 3 - GO ENRICHMENT 1000 simulations 
list size CRAM WAME LMW FC t RANDOM 
200 13.76 11.56 11.5 10.02 13.04 6.91 
400 17.8 15.07 15.91 11.2 14.62 6.97 
800 21.61 18.67 20.11 13.4 15.7 7.01 
 
 
 
In dataset 4 CRAM had the highest enrichment for gene list sizes 800 and had similar 
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enrichment to standard t statistics for sample size 400 (Table 5). 
 
Table 5 – Enrichment (average -log p-value) for gene lists of different size for each 
method.  Highest enrichment for each sample size in bold.  Standard errors are 
approximately 0.25 for all methods excluding RANDOM with SE = 0.04.  If the highest 
and second highest enrichment are not significantly different, the two enrichment values 
are made bold.   
DATASET 4 - GO ENRICHMENT 1000 simulations 
list size CRAM WAME LMW FC T RANDOM 
200 70.0 53.37 53.13 26.43 92.5 6.53 
400 84.75 74.7 70.41 22.16 85.0 6.97 
800 68.59 63.2 61.77 24.07 62.06 6.88 
 
 
 
4.4.3 Enrichment measures – CRAM-GC 
To measure the results, each sample had its gene enrichment evaluated separately.  Given 
that some tested datasets are heterogeneous (biologically dissimilar) in which case, 
combining samples is of questionable use.  Our goal is to measure the improvement in 
GO enrichment from every individual sample.   
 In heterogeneous datasets, standard methods for evaluating the gene-specific variance 
σi2, assume a gene-specific variance moderation parameter equal to zero, meaning the 
gene-specific variance is constant for all genes.   This constant variance assumption has 
been shown to produce higher overlap between samples even in homogeneous datasets.  
In this sense, we chose to compare GO enrichment of every array using the original fold 
change values, compared to CRAM-GC expected fold change using (4.13).  Also, the 
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sample-specific variance from other approaches is assumed constant within the sample, 
meaning that it does not influence the rank order of the genes when selecting for a gene 
list using a single sample.  Thus, ranking genes from a single sample by their original 
fold change values is the equivalent of ranking them by using other common approaches.  
 The p-value for the most significant GO category for every sample comparing the 
original fold change log intensity value with CRAM-GC expected fold change was 
calculated, where  the corresponding –log(p-value) for the two approaches was averaged 
for all samples for each dataset.  A one tail p-value for differences of means of between 
the two averages of –log(p-value) for CRAM-GC and original fold change  was 
generated for every gene list sizes of 200, 400 and 800.   In addition, a measure of 
percentage of times CRAM-GS had superior enrichment compared to the original value 
was performed (tables 6 to 12).  In all tables CRAM-GC had a significant p-value (< 
0.05) for all genes list sizes.  When comparing the number of times CRAM-GC had 
superior enrichment, CRAM-GC was marginally lower in (Table 6) (gene list size 200) 
and (Table 7) (gene list size 400), but superior in all other cases.    
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Table 6 – Enrichment (average -log p-value) for gene lists of different sizes for CRAM-
GC and the original fold change (columns 1 and 2).  P-values for differences of means 
(over 80 samples) between columns 1 and 2 were generated (column 3).  In column 4 we 
present the % of times CRAM-GC had superior enrichment to the original fold change 
value (in case there were ties, a 0.5 count was assigned to both Original FC and CRAM-
GC). 
DATASET 1 – 80 paired samples 
List size Original-FC CRAM-GC p-value diff % Cram > Orig. 
200 18.57 19.15 2.0E-02 45%
400 26.35 34.15 8.7E-10 72%
800 23.24 28.22 2.4E-08 69%
 
Table 7 – Enrichment (average -log p-value) for gene lists of different sizes for CRAM-
GC and the original fold change (columns 1 and 2).  P-values for differences of means 
(over 88 samples) between columns 1 and 2 were generated (column 3).  In column 4 we 
present the % of times CRAM-GC had superior enrichment to the original fold change 
value (in case there were ties, a 0.5 count was assigned to both Original FC and CRAM-
GC). 
DATASET 2 – 88 paired samples 
List size Original-FC CRAM-GC p-value diff % Cram > Orig. 
200 18.50 19.17 6.8E-03 57%
400 27.62 33.86 2.0E-07 49%
800 26.61 30.66 2.4E-08 56%
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Table 8 – Enrichment (average -log p-value) for gene lists of different sizes for CRAM-
GC and the original fold change (columns 1 and 2).  P-values for differences of means 
(over 16 samples) between columns 1 and 2 were generated (column 3).  In column 4 we 
present the % of times CRAM-GC had superior enrichment to the original fold change 
value (in case there were ties, a 0.5 count was assigned to both Original FC and CRAM-
GC). 
DATASET 3 – 16 paired samples  
List size Original-FC CRAM-GC p-value diff % Cram > Orig. 
200 13.35 33.82 1.7E-03 89%
400 13.39 34.37 8.7E-04 98%
800 13.03 28.90 7.6E-04 73%
 
Table 9 – Enrichment (average -log p-value) for gene lists of different sizes for CRAM-
GC and the original fold change (columns 1 and 2).  P-values for differences of means 
(over 10 samples) between columns 1 and 2 were generated (column 3).  In column 4 we 
present the % of times CRAM-GC had superior enrichment to the original fold change 
value (in case there were ties, a 0.5 count was assigned to both Original FC and CRAM-
GC). 
DATASET  4 – 10 paired samples 
List size Original-FC CRAM-GC p-value diff % Cram > Orig. 
200 6.60 8.84 2.8E-06 90%
400 7.91 9.22 1.2E-03 78%
800 8.07 9.16 3.4E-02 58%
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Table 10 – Enrichment (average -log p-value) for gene lists of different sizes for CRAM-
GC and the original fold change (columns 1 and 2).  P-values for differences of means 
(over 174 samples) between columns 1 and 2 were generated (column 3).  In column 4 
we present the % of times CRAM-GC had superior enrichment to the original fold 
change value (in case there were ties, a 0.5 count was assigned to both Original FC and 
CRAM-GC). 
DATASET 5 – 174 unpaired samples 
List size Original-FC CRAM-GC p-value diff % Cram > Orig. 
200 38.19 50.18 1.2E-07 62%
400 44.54 59.41 1.5E-11 77%
800 50.86 65.47 2.1E-13 79%
 
 
Table 11 – Enrichment (average -log p-value) for gene lists of different sizes for CRAM-
GC and the original fold change (columns 1 and 2).  P-values for differences of means 
(over 36 samples) between columns 1 and 2 were generated (column 3).  In column 4 we 
present the % of times CRAM-GC had superior enrichment to the original fold change 
value (in case there were ties, a 0.5 count was assigned to both Original FC and CRAM-
GC). 
DATASET 6 – 36 unpaired time course samples  
List size Original-FC CRAM-GC p-value diff % Cram > Orig. 
200 91.76 93.06 3.6E-02 65%
400 132.50 136.68 1.5E-05 67%
800 138.67 142.17 1.5E-08 79%
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Table 12 – Enrichment (average -log p-value) for gene lists of different sizes for CRAM-
GC and the original fold change (columns 1 and 2).  P-values for differences of means 
(over 269 samples) between columns 1 and 2 were generated (column 3).  In column 4 
we present the % of times CRAM-GC had superior enrichment to the original fold 
change value (in case there were ties, a 0.5 count was assigned to both Original FC and 
CRAM-GC). 
DATASET 7 – 269 unpaired samples 
List size Original-FC CRAM-GC p-value diff % Cram > Orig. 
200 31.00 63.62 4.0E-47 93%
400 29.71 55.71 7.8E-42 91%
800 35.93 59.03 1.1E-53 88%
 
4.5 DISCUSSION AND CONCLUSION 
  We have presented the Calibration Regression Analysis of Microarrays (CRAM) 
and shown that CRAM had superior performance compared to other approaches. Similar 
to existing approaches, CRAM models gene-specific variance as a function of intensity 
(Baldi and Long 2001; Sartor, Tomlinson et al. 2006; Fodor, Tickle et al. 2007; Astrand, 
Mostad et al. 2008; PLW-Astrand 2008).  CRAM improves on existing approaches by 
explicitly modeling the dependency between intensity level and sample-specific variance. 
The estimation of different sample-specific variances for every gene in each sample was 
shown to improve the accuracy in testing for differential expression.  In addition, CRAM-
GC was shown to use effectively the correlation between genes, producing a major 
improvement in GO enrichment compared to the standard CRAM model.  CRAM-CG 
was also shown to be applicable to heterogeneous datasets. 
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4.5.1 Overcoming biological heterogeneity  
We described in section 4.4.1, the distortions in estimating gene-specific variance in 
datasets with high heterogeneity.  In datasets 1, 2 and 4, extreme values for the 
standardized values of expected ∆ log-intensity indicate a strong underestimation of 
gene-specific variance.  Our results show CRAM overcomes some limitations of 
distortions in gene-specific variance estimates, which are more extreme in heterogeneous 
datasets, by finding that the optimal gene-specific variance moderating factor α = 0, 
which is equivalent to assuming a constant gene-specific variance.  However, estimating 
gene-specific variances in heterogeneous datasets based on the expected log-intensity, 
will generate underestimated variances resulting in inflated t-statistics, such that gene 
lists based on these t-statistics will have inferior enrichment.   
Studies have shown that different genes have different variances in expression in 
homogeneous datasets (Bar-Even, Paulsson et al. 2006; Wentzell, Karakach et al. 2006).  
On the other hand, recent studies have shown than in homogeneous datasets, a higher 
concordance between samples is achieved using fold change measures (Shi, Perkins et al. 
2008).    Curiously, when estimating t-statistics measures in homogeneous datasets, 
modeling gene-specific variances based on optimizing for the highest concordance 
between samples, often results in sub-optimal GO enrichment.  This is still a highly 
debatable topic in current literature.   
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4.5.2 Gene enrichment performance  
Although LMW is an extension of WAME, modeling gene-specific variance as a 
function of intensity, WAME performed better than LMW most of the time (Kristiansson, 
Sjogren et al. 2005; Bar-Even, Paulsson et al. 2006; Kristiansson, Sjogren et al. 2006; 
Wentzell, Karakach et al. 2006; Astrand, Mostad et al. 2007; Sjogren, Kristiansson et al. 
2007; Astrand, Mostad et al. 2008).  This behavior can be attributed to over fitting of the 
gene-specific variance by LMW, due to the non-normality of the distribution of ∆ log-
intensity values.  CRAM, which is similar to WAME with the main difference being the 
modeling of sample-specific variance within each sample, is also robust to over fitting of 
the gene-specific variance.  In general, modeling gene-specific variance as a function of 
intensity by CRAM (using groups) proved to be more robust than LMW and at the same 
time, generated higher enrichment than WAME, making CRAM biologically accurate 
with heterogeneous and homogeneous data. 
The enrichment performance of CRAM gene correlation (CRAM-GC) was superior 
in every tested dataset, showing that the untransformed fold change values were 
significantly less enriched than when gene correlations between genes were taken into 
account.   This superior enrichment was shown in paired and non-paired designs, in two 
and one-color microarrays, in single time point and time course data.   However, in order 
to fully achieve the benefits of using gene-correlation, it is necessary to have a datasets 
with number of samples greater or equal to 10.  The primary consequence of using a 
sample dataset too small is that correlations will be too unstable with high correlations 
being detected as a result of chance (even after Fisher’s transformation adjustment), 
121 
 
generating a large number of false positive genes, thus resulting in reduced GO 
enrichment.  
 CRAM-applied was also applied to datasets 1 to 4, where most significant GO 
enrichment categories for genes higher in Q and similarly for genes higher in NQ (tables 
13and 14) were obtained by combing all samples. 
Table 13 – Most significant GO categories for gene lists significantly more expressed in 
Q than in NQ (p-value < E-6).  An additional list was obtained for a sample of size 200 
(due to the fact that the gene list based on p-value was not enriched).   On the column 
named ‘p-value’ we have the p-value for the column ‘# of genes’.  On the right hand side 
we have the ratio between observed number of genes for GO category and expected 
number of genes under the random assumption. 
Q Gene lists – Biological Process GO enrichment 
DATASETS  GO category  # genes  
total in 
category  sample 
p‐
value  ratio
Dataset 1 
Ethanol Metabolic 
Process  5  11  59 
8.6 E‐
06  40 
   Fermentation  5 16 59  7.8E‐05 30
   Monocarboxylic Acid MP 22 132 200  1.9E‐07 5
Dataset 2  Monocarboxylic Acid MP 14 132 60  4.9E‐09 10
   Amine Catabolic Process 4 7 60  5.8E‐05 65
Dataset 3 
Glucose Catabolic 
Process  6  39  64  5.5E‐04  15 
Dataset 4 
Pyruvate Metabolic 
Process  13  40  68  7.4E‐15  30 
   Glycolysis  9 22 68  6.2E‐11 35
 
Table 14 – Most significant GO categories for gene lists significantly more expressed in 
NQ than in Q (p-value < E-6).  An additional list was obtained of size 200.  An additional 
list was obtained for a sample of size 200 (due to the fact that the gene list based on p-
value was not enriched).   On the column named ‘p-value’ we have the p-value for the 
column ‘# of genes’.  On the right hand side we have the ratio between observed number 
of genes for GO category and expected number of genes under the random assumption. 
NQ Gene lists – Biological Process GO enrichment  
DATASETS  GO category 
# 
genes   total in category 
sampl
e  p‐value 
rati
o 
Dataset 1  Hexose Trasport  6  25  62  2.50E‐05 25 
Dataset 2  Hexose Trasport  14  132  200  4.9E‐09  10 
Dataset 3  Asparagin MP  6  39  58  5.5E‐04  15 
Dataset 4  Carboxylic Acid MP  13  40  65  7.4E‐15  30 
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Both datasets 1 and 2 shared similar GO categories for both Q (“Monocarboxylic Acid 
Metabolic Process”).  Similarly for NQ, both datasets shared the same GO categories 
(“Hexose Transport”).   Dataset 4 most significant GO categories for Q (“Pyruvate MP” 
and “Glycolysis”) are subsets of “Monocarboxylic Acid MP”.  Curiously, for NQ, dataset 
4 most significant GO category was Carboxylic Acid Metabolic Process, which is a 
parent category of “Monocarboxylic Acid MP”, suggesting that some genes from the 
category Carboxylic Acid may be more highly expressed in Q and others more highly 
expressed in the NQ cell population. 
 
4.5.3 Computational speed factors 
CRAM was written in MATLAB, and was shown to be highly computationally 
efficient, taking an order of magnitude less time, to score the datasets on the same 
computer, as compared to other sample-specific variance modeling approaches. The 
treatment of each sample as an individual dataset using the framework in (Ibrahim and 
Chen 2000), combined with an empirical Bayes approach and measurement error is the 
main reason for this efficiency (HerbertR. 1956; Fuller 1987).  
4.5.4 Future applications 
We intend to apply CRAM to time series microarray data, which can be highly 
heterogeneous depending upon the temporal dynamics of the system under study. To 
accurately model log-intensity from time series data, CRAM needs to be enhanced to 
have gene-specific variance σ2ij for every sample j and for every gene i as opposed to 
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using a constant gene-specific variance  σi2 for every sample for gene i.  More robust 
estimation of the weights can be developed where each sample is classified into more 
groups. Instead of grouping genes within each sample based on their transformed log 
intensity levels, it is possible to group genes using GO biological process categories, 
which is likely to better model interactions among genes, leading to improved 
performance.  Finally, similar experiments can be combined by using each gene’s 
expected log-intensity (or ∆ log-intensity) from a previous experiment, as the prior 
expected log-intensity in the current experiment.    
 
4.6 ACKNOWLEDGMENTS 
We thank three unknown reviewers for their insightful comments.  We thank Diego 
Martinez and Michele Guindani for their comments on an earlier version of this work. 
 
 
 
 
 
 
 
124 
 
4.7 SUPPLEMENTAL MATERIALS 
4.7.1 Sample variance distortion in biological heterogeneous datasets 
Estimation based on gene sample variance in heterogeneous datasets, can highly 
distort the estimation of gene-specific variance, and thus distorts gene-expression 
variance estimates.  The assumption of a log-intensity expectation τi for each gene i in 
estimating gene sample variances, does not hold in the presence of high biological 
heterogeneity where each gene i for each   sample j, has a more specific (to gene i and 
sample j) expectation τij.  When assuming a fixed τi for a gene i, the error component for 
gene i in sample j, is based on the deviation between τi and xij, whereas the true error 
should be based on the deviations between τij and xij.  As a result, assuming samples 
have the same weights, when estimating the gene sample variance si2, many approaches 
assume the true unknown sum of errors across arrays to be ∑
=
k
j 1
 (xij - τi)2  when it should 
be ∑
=
k
j 1
 (xij -τij)2.   We can write ∑
=
k
j 1
 (xij - τi)2 as the sum  
 ∑
=
k
j 1
 (xij - τij)2  + ∑
=
k
j 1
 ( τi - τij)2  - 2∑
=
k
j 1
 (xij - τij) (τi - τij) .  When true errors are small, 
that is, when xij is close to τij, the third term becomes very small and we have  
∑
=
k
j 1
 (xij - τi)2  ≥∑
=
k
j 1
 (xij- τij)2 , showing an overestimation of the sample variance when 
using an overall ui.  On the other hand, when  
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∑
=
k
j 1
 ( τi - τij)2  < 2∑
=
k
j 1
  (xij - τij ) (τi - τij ), we have an underestimation of the variance.  
In Fig.1, the observed heterogeneity of datasets 1, 2 and 4, sample variance is 
underestimated, suggesting the presence of large errors, where xij is far from τij relative to 
the distance between τi and τij.  In datasets 1 and 2, underestimation of gene sample 
variance was extreme to the point that it was more accurate in some cases, to assume a 
homogeneous (constant) gene-specific variance, than modeling gene-specific variance 
based on the gene sample variance si2.   
 
4.7.2 Proof:  P(τi | xij ) ~ N((µi + wj xij )/(1+ wj) , σi2 /(1+ wj ) ). 
We assume that every gene i for an sample j, has a corresponding random variable τi 
with distribution P(τi) ~ N(µi, σi2) which has the known prior expectation µi for gene i 
and where  wj > 0, is an unknown parameter which is constant within sample j, 
representing the level of confidence we have in this sample. The parameter wj is also the 
inverse of the sample-specific variance defined as 1/wj.  Given this, we can write  
 P(xij | τi  = λi) = P(eij + τi| τi  = λi) = P(eij + λi| τi  = λi) ~ N(λi , σi2/wj ), 
since eij  is N(0, σi2/wj )-distributed. 
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We pause to recall a convention from Bayesian statistics. If one has two random variables 
X and Y, one can write the conditional distribution P(Y|X) as 
     P(Y|X) = P(X,Y)/P(X) = P(Y)P(X|Y)/P(X).   
This is a form of Bayes’ Theorem. Now, we consider 1/P(X) as a constant of 
proportionality since X is given and fixed in the conditional probability P(Y|X).  Thus, 
we can write 
      P(Y|X)  α  P(Y)P(X|Y)  
where α is the symbol for proportionality (Lee 1997). 
By the above discussion, we then have P(τi | xij )  α  P(xij | τi) P(τi).  
Let Z be a random variable that has the distribution 
  P(xij | τi  = λi) P(τi)  ~  N(λi , σi2/wj ) N(µi, σi2) 
 Then  
P(Z = z) = (
2
1  2π σi2 w1/2)exp(–
2
1 {wj(z– xij)2 + (z– µi )2}/ σi2 } ) which is proportional to   
exp(–
2
1 {wj z2  –  2wj xij z + wjx2ij + z 2  – 2 zµi + µ2i }/ σi2 } )  =  
exp(–
2
1 { (wj+1) z2  –  2 z (wjxij + µi ) + wjx2ij + µ2i }/ σi2) =  
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exp(–
2
1 { (wj+1)[ z2 + 2(wj xij + µi )/(1+ wj) z+ wj x2ij /(1+ wj) + µ2i /(1+ wj)  ]}/ σi2) and by 
completing the square by adding and subtracting the term  (xijwj  + µi )2/(1+ wj)2 in the part 
of the equation between the brackets, we have  
exp(–
2
1  [z– (xij wj +µi ) /(1+ wj)]2 /(σi2/(1+ wj)))exp(–
2
1  [wjx2ij –(xijwj+µi)2/(1+ wj)]/ σi2).   
Since the second exponential term does not have the term z, it is just a proportionality 
factor, thus, we can say the previous expression is proportional to the first exponential 
term 
exp(–
2
1  [z– (xij wj + µi )/(1+ wj)]2/ (σi2/(1+ wj))  ) 
which is proportional to a normal distribution with mean (µi + wj xij)/(1+ wj) and  
variance        σi2 /(1+ wj ). Thus we can write  
P(τi | xij ) α  N( (µi + wj xij)/(1+ wj) , σi2 /(1+ wj ) ) 
and we are done. 
 
4.7.3 Proof: P(τi | X) ~ N(   (µi +∑
=
k
j 1
 wj xij )/(1+∑
=
k
j 1
 wj )  ,  σi2 / (1+∑
=
k
j 1
 wj)   ). 
P(τi | xi1,  xi2 , … ,  xik , w1 , w2 , … , wk ) is proportional to  
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P(xi1,  xi2 , … ,  xik | w1 , w2 , … , wk , µi ) P(τi) and by independence between 
samples,  
P(xi1,  xi2 , … ,  xik | w1 , w2 , … , wk , τi ) is proportional to  
P(xi1 | w1 , τi ) P(xi2 | w2 , τi )… P(xik | wk , τi ) and therefore 
P(τi | xi1,  xi2 , … ,  xik , w1 , w2 , … , wk ) is proportional to 
P(xi1 | w1 , τi) P(xi2 | w2 , τi)… P(xik | wk , τi ) P(τi ) which is the kernel of a Normal 
distribution with mean (µi +∑
=
k
j 1
 wj xij )/ (1+∑
=
k
j 1
 wj ) and variance σi2 / (1+∑
=
k
j 1
 wj).   
This last step can be shown in greater detail if we follow the same steps as in 4.7.2 where 
we complete the square and get an expression proportional to  
exp(  –
2
1  [ (τi – (µi +∑
=
k
j 1
 wj xij )/ (1+∑
=
k
j 1
 wj ) ]2 / ( σi2 / (1+∑
=
k
j 1
 wj) )  ). 
 
4.7.4 Estimating wj , the weight parameter of a sample j. 
Remembering that Yj = {y1j, y2j, … , ynj} is an estimate of Xj  ={x1j, x2j, ... , xnj},  let the 
vector  µ = {µ1 , ... ,µn} be the vector of known prior expectations and denoting              
T = {τ1,τ2,…,τn} the vector of unknown expectations, from (4.4) or 4.7.2,  we have     
E[T | Xj ] = (µ + wj Xj )/(1+ wj ). 
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By performing the regression Yj = E[T | Xj ] , we estimate wj which minimizes the loss 
function Lj, denoted as the sum ∑
=
n
i 1
  ((µi + wj xij )/(1+ wj) - yij )2 , we set the derivative    
 ∂ Lj / ∂ wj = 0, and thus ∑
=
n
i 1
2((µi + wj xij )/(1+ wj) - yij )( xij - µi )/(1 + wj)2 = 0 . 
Since the term (1+wj)2 is constant throughout sample j, we can simplify the equation by 
making ∑
=
n
i 1
((µi + wj xij )/(1+ wj) - yij )( xij - µi ) = 0 . 
Thus, solving for wj we get  
                 wj = ( ∑
=
n
i 1
  (yij - µi )( xij - µi )  ) / ( ∑
=
n
i 1
  (xij - yij )( xij - µi )).      (4.7) 
 
4.7.5 CRAM algorithm 
We present the CRAM algorithm where the CRAM z-statistic is calculated.  
/*Calculation of weights wij, for all n genes, k samples and g groups per sample.*/ 
for each sample j: 
1- Group genes into three groups using their intensity values, by sorting in 
descending order by xij  
for each group g:  
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a. Perform a linear regression where Xj ={x1j, x2j, ... , xnj}is estimated using 
the remaining set of Xl where  l ≠  j , generating a set of Yj = { y1j, y2j, … , 
ynj}  predicted values.   
b. Calculate Wgj = (∑
=
n
i 1
Ig(yij - µi)( xij - µi))/(∑
=
n
i 1
 Ig(xij - yij)( xij - µi)) , 
where Ig is the indicator function for a gene belonging to group g. 
       end loop 
c. For every gene i in array vector j, assign the weight wij = Wgj. 
  end loop 
 /*Calculation of z-statistic*/ 
 for each gene i: 
      1- Get the estimate ui for the unknown expectation τi: 
 ui = (µi +
 
∑
=
k
j 1
 wij xij  )/ (1+∑
=
k
j 1
 wij)   
      2- Calculate the weighted sample variance:   
si2 = ∑
=
k
j 1
 wij(xij-ui)2/ ( (∑
=
k
j 1
 wij)2  - ∑
=
k
j 1
 wij2) / ∑
=
k
j 1
 wij )   
      3- Calculate the average of all si2:  
V2 = ∑
=
n
i 1
si2 / n 
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      4- Use optimal α and estimate the gene-specific variance:    
i
2 = αsi2 + (1- α) V2 
         5- Generate the estimate for i 
i= (µi +
 
∑
=
k
j 1
 wij xij  )/( i ∑
=
k
j 1
 wij (1+ wij) )1/2    
    6-  Calculate i_m =∑
=
n
i 1
 i / n   and  S  =  ( ∑
=
n
i 1
( i – i_m )2/(n-1)  )1/2 
     7- Generate the CRAM z-statistic, which is approximately N(0,1): 
zi =  ( i   - i_m)/S 
   A two tail p-value for each gene can be generated by 2Ф(-|zi|), where Ф is the 
standard Normal cumulative distribution function. 
end loop 
 
4.7.6 Estimating the variance of the posterior expectation ui 
To calculate the variance of the estimated expectation ui, we have 
Var(ui) = Var((µi +
 
∑
=
k
j 1
  wj xij  )/ (1+∑
=
k
j 1
 wj ) ) = ∑
=
k
j 1
  w2j Var(xij )/ (1+∑
=
k
j 1
 wj )2 .   
By (4.1) and (4.2) variance of xij is given by  
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Var(xij) = Var(τi )+ Var(eij) = σi2 + σi2/ wj =  σi2 (1+ wj)/ wj  and thus 
Var(  (µi +
 
∑
=
k
j 1
  wj xij  )/ (1+∑
=
k
j 1
 wj ) )   = σi2 ∑
=
k
j 1
  wj(1+ wj)  /  (1+∑
=
k
j 1
 wj )2       
(4.8) 
 
4.7.7 Optimizing the α parameter 
In this paper, we will set α = 0.9 for homogeneous datasets (datasets 3 and 4) and α = 0 
for heterogeneous datasets (datasets1 and 2).   This criterion for selecting α is used to 
generate the CRAM z-statistic in (4.11) which is used for generating lists of size 200, 400 
and 800.  We present two methods to estimate α.    
4.7.8 α estimation for the whole dataset (Method 1) 
The main assumption is that the α which best models the upper tail of a true N(0,1), is the 
α that best moderates the gene-specific variance.  We chose the 90th percentile (q = 0.90) 
to define the upper tail, although other values could be used as well.  An individual α is 
optimized for each dataset. 
For every simulated α = 0, 0.1, 0.2,…, 0.9, 1.0. 
      1. Estimate ui for every gene i, using equation (6) 
      2. Estimate σi2 for every gene i using equation (10).  
      3. Generate the z-statistic ai by (9). 
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      4. Generate a’i = ai – {mean of ai over all n genes}. 
      5. Sort in descending order by a’i. 
      6. Select a’i corresponding to the 90th percentile.  Call this a’90th. 
      7. Generate p90th = Ф(-|a’90th|) where Ф is the Standard Normal cdf. 
      8. Calculate ∆(α) = | p90th – (1 – q) | = | p90th – 0.10 |. 
End loop  
Select α that generates the smallest ∆(α) for all simulated values of α . 
 
4.7.9 α estimation for each simulated sample (Method 2): 
If the research conducting the microarray experiment has a small dataset (small number 
of samples), this method will be more appropriate than method 1.  In order to estimate α, 
the dataset is divided into test data and hold out data.  The main assumption is that the 
optimal alpha is the one that has the highest overlap between the test data (Test) and the 
hold out data (Ho). 
For every simulated l = 1,…,11 
     Let α = 0.1(l-1) 
    For each sample j = 1, …, k  
         1.  Select array j as the hold data.  Select the remaining arrays as test data.  
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         2.  Use the weight wj of sample j, to estimate the expectation of the hold out data. 
Ho_ui  = (µi +
 
wj xij)/(1+ wj) 
        3.  Use the weights excluding wj to estimate the expectation of the test data. 
Test_ui = (µi +
 
∑
≠=
k
jl 1
 wil xil  )/ (1+∑
=
k
j 1
 wil) 
        4. Estimate si2 for every gene i in the test data. 
si2 = ∑
≠=
k
jl 1
 wil (xil - Test_ui)2/ ( (∑
=
k
l 1
 wil)2  - ∑
=
k
l 1
 wil2) / ∑
=
k
l 1
 wil )   
        5. Calculate the average of all si2 in the test data:  
                V2 = ∑
=
n
i 1
si2 / n 
       6. Estimate σi
2 for every gene i in the test data using the simulated α.  
i
2 = αsi2 + (1- α) V2 
           7. Standardize the expectations of the hold out data and test data by dividing by 
σi_hat.  
                                                  Test_ti = Test_ui / i 
       Ho_ti = Ho_ui / i 
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        8. Sort both Test_t  and Ho_t  in descending order.  
         9.  In both sorted Test_t  and Ho_t , select for the top C genes. 
  10. Count the number of overlapping genes after selection between Test_t and Ho_t, 
and call this Pre_overlap(l , j). 
    End loop 
11. Get the mean of the Pre_overlap(l , j) over all j.  Call this Overlap(l). 
End loop 
12. Set pos = Argmax(Overlap). 
13. Optimal α is equal to 0.1(pos-1). 
 
4.7.10 Other versions of CRAM 
4.7.10.1 CRAM-binary 
   This is a robust version of CRAM and was developed to handle datasets with a high    
incidence of outliers.   Instead of using its original values, all samples Xj are ranked 
and categorized as a dichotomous variable.    
 
  4.7.10.2 CRAM expectation maximization (CRAM-EM) 
      This is the fastest version of CRAM.   It replaces the regression step in 4.3.3.2 by 
assigning initial weights w1, w2,…, wk = 1.   In this version, Xj is also estimated using 
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the remaining samples but instead of using a regression, Xj is estimated using a 
iterative procedure where a weighted average is used.  Thus Yj ,  the estimate of Xj  is 
the vector denoted by (y1j , y2j , … , ynj ), where yij   = ( ∑
=≠
k
jl 1
wlxij  ) /  ( ∑
=≠
k
jl 1
wl ) .   
 
   4.7.11.2 CRAM-EM Algorithm 
1- Assign initial weights w1, w2, …, wk = 1. 
   For every iteration until convergence of the weights 
 For every sample j  
2- Estimate Yj using the current weights, such that  
  yij   = ( ∑
=≠
k
jl 1
wlxij  ) /  ( ∑
=≠
k
jl 1
wl ).   
3- Estimate a new weight for sample j such that                                                  
                     wj =( ∑
=
n
i 1
  (yij - µi )( xij - µi ) ) / ( ∑
=
n
i 1
  (xij - yij )( xij - µi )). 
Assuming negative weights are not possible, if wj < 0 we make wj = 0. 
     End loop 
      4 - Update all weights w1, w2, …, wk . 
      5- If convergence then end. 
   End loop        
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Once the weights are defined, the rest of the procedure is identical to CRAM.   The as the 
number of samples increase, the EM procedure becomes much faster than using a 
multiple linear regression, with the same performance. 
 
4.7.11.3 CRAM-binary algorithm 
 Define γ, a cutoff value such that 0  ≤ γ  ≤ 1. 
  For every sample j 
 Sort each Xj in ascending order and define Vj   = {v1j , v2j , …, vnj } where   
  vij  = 1 if xij is in the top γ proportion of the total number of genes and vij  = 0 
otherwise.  
  End Loop 
  As a result Vj will have approximately γ values equal to 1 and 1 – γ values equal to 0. 
1- Assign initial weights w1, w2,…, wk = 1. 
  For every iteration until convergence of the weights 
 For every sample j  
2- Estimate Yj   using the current weights Yj   such that  
Yj  =  (1 + ∑
=≠
k
jl 1
wl Vj   ) /  (1/γ  + ∑
=≠
k
jl 1
wl ). 
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3- Estimate a new weight wj for sample j such that        
                   wj = γ
γ−1 Cov(Yj , Xj )/(Var(Xj ) – Cov(Yj , Xj )). 
Assuming negative weights are not possible, if wj < 0 we set wj = 0. 
     End loop 
      4 - Update all weights w1, w2, …, wk . 
      5- If convergence then end. 
  End loop        
  6- Generate the final estimate ui for every gene given by   
ui  = (1 +∑
=
k
j 1
wj vij   ) /  (1/γ  +∑
=
k
j 1
wj ).  Note: if prior probabilities πi are known, 
then        ui  = (1 +∑
=
k
j 1
wj vij   ) /  (1/πi  +∑
=
k
j 1
wj ). 
 
4.7.11.4  CRAM-GC algorithm 
1. Generate a Spearman correlation matrix with all samples.  
For every sample j 
2. Select the maximum correlation ρj among all the remaining samples. 
3. Generate the sample weight aj is given by 
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   aj =( ∑
=
n
i 1
  (yij - µij )( xij - µi ) ) / ( ∑
=
n
i 1
  (xij - yij )( xij - µi )).      
End loop 
For every gene i 
4. Generate a Spearman correlation matrix with all genes.  
5. Select the maximum absolute correlation |ρi| among all the remaining genes. 
6. Use the Fisher’s transformation to get a corresponding zi statistics 
  zi = f(ρi) = 0.5(k-3)1/2ln( (1+|ρi| )/( 1- |ρi| )   
7. Let α = 1/n be the level of significance and let z0i = Φ-1(1-α), where Φ-1 
represents the inverse of the Normal cumulative distribution function. 
8. Let f--1(z0i) = (exp{2z0i/(k-3)1/2} – 1)/(exp{2z0i/(k-3)1/2} + 1) 
9. Let z1i = z0i + f--1(z0i) (k-3)1/2/2(k-1). 
10. Let zi’= zi – z1i.  If zi’ < 0 then set zi’ = 0. 
11. By using the inverse Fisher transformation on zi’, generate ρi’ = f--1(zi’).   
 
12. Generate the gene weight given by  
gi = ( ∑
=
k
j 1
  (ci|ρi’|/|ρi| xij - µij )( xij - µi ) ) / ( ∑
=
k
j 1
  (xij - ci|ρi’|/|ρi| xij )( xij - µi )). 
End loop 
For every array j 
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    For every gene i 
    13.  Generate the sample-gene weight wij =   aj gi. 
              14.  Generate E[τij | xij]  = (µij + wij xij ) /(1+ wij ).         
       End loop 
End loop 
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Chapter 5 - DISCUSSION 
 
5.1 KEY IDEAS 
The studies presented in the previous chapters describe applications in genomics 
of three key ideas: concordance, association and multi-dimensional differential 
expression.   For each of them we have presented applications that identify differentially 
expressed genes in a computationally efficient way.  In chapter 2 a general framework 
was described in which concordance was used to obtain the significance of multi-
dimensional gene list overlaps.  In chapter 4, CRAM models were developed where 
concordance and association concepts were combined to generate superior measures of 
differential expression in unsupervised data.  In these models, variance in gene 
expression was estimated within and between samples, and was applied to heterogeneous 
and homogeneous datasets.  In chapter 3 we described the SDI approach, which models 
differences in fluorescence intensity in multiple dimensions in order to detect 
heterogeneous cell populations in a high-throughput flow cytometry experiment. 
 
5.2 GENE LIST OVERLAPS  
The novel method to estimate the significance of gene list overlaps described in 
chapter 2 expands on the currently used GO term Finder  application (GOTermFinder ; 
Boyle 2004) by estimating the significance of overlaps between multiple sets of genes.  
An example was described in figure 4, where two gene lists were combined with the set 
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of genes belonging to the ‘unknown’ GO category, in which the triple overlap was highly 
significant.  One immediate application of this method is in the identification and 
classification of candidate genes into either a new GO category or a previously known 
one.  In addition, we have shown that when measuring the significance of overlaps 
among three or more sets of genes, the order in which successive pairwise overlaps are 
obtained, is critical, resulting in a different p-value for each different order.   Another 
way to measure the significance of higher order overlaps would be to apply 
multidimensional hypergeometric distributions (Kerov 2005), however, we have shown 
the limitations of this method since it limited to a single type of higher-order overlap 
(assuming independence among all sets), and thus, it is likely to miss some important 
lower-order overlaps, that are key to identify the optimal overlap.  Based on the 
preliminary results in chapter 2, we hypothesize that important biological interactions can 
be detected and easily interpreted by using the method we developed.  
 
5.3 CONCORDANCE AND MEASURES OF DIFFERENTIAL 
EXPRESSION  
 
5.3.1 Limitations of standard t-statistics 
Standard t-statistics applied to microarrays are based on assumptions that are 
often violated.  The normality assumption of the expected fold change for each gene 
often does not hold due to large distortions in the tails of the distribution in most datasets 
(Fodor, Tickle et al. 2007).   In order to improve the standard t-statistics, several 
variations of moderated t-statistics have been developed in which the variance in intensity 
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level for each gene is smoothed using highly sophisticated computational procedures 
applied to supervised data (Smith 2004; Kristiansson, Sjogren et al. 2005; Kristiansson, 
Sjogren et al. 2006; Astrand, Mostad et al. 2007; Astrand, Mostad et al. 2008) .   
Nevertheless, even moderated t-statistics often produce gene lists with lower 
reproducibility compared to genes lists generated using fold change.  In order to 
maximize concordance between samples, we described a procedure in which t-statistics is 
moderated so that concordance between gene lists is maximized.  
 
5.3.2 Concordance and moderated t-statistics 
Most of the currently used moderated t-statistics moderation algorithms have been 
developed for supervised datasets where a dependent variable is present.  In these 
algorithms a variance moderation parameter is optimized in such a way that the 
moderated t-statistics best predicts the dependent variable.   Since our datasets are all 
unsupervised, we had to find alternative ways to moderate gene-specific variances. 
In chapter 4 we have presented an algorithm that moderates the variance such that 
the average concordance between samples is optimized.  As expected, the optimal 
variance moderating parameter was equal to zero for all heterogeneous datasets tested, 
which implies that the moderated t-statistics has the same rank ordering as fold change.  
On the other hand, even in the homogeneous datasets (3 and 4), the variance moderating 
parameter was equal to zero, confirming the assumption that optimal concordance is 
reached by using fold change measures (Shi, Perkins et al. 2008). 
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5.3.3 Concordance vs. GO enrichment    
Fold change and t-statistics (moderated or not) are the two most common methods 
to evaluate differential expression.   As described in detail by (Tusher, Tibshirani et al. 
2001; Shi, Tong et al. 2005; Tu, Kudlicki et al. 2005; Shi, Reid et al. 2006; Shi, Perkins 
et al. 2008) when using biological replicates to measure concordance between gene lists, 
fold change is almost always superior to standard t-statistics and similarly to moderated t-
statistics.  However, although fold change is more likely to generate a higher 
concordance than a t-statistics, we should ask the question: Does a higher concordance 
imply in a higher GO enrichment?  Preliminary results show that although a hypothetical 
gene list A can have a lower concordance than a gene list B, gene list A can have higher 
GO enrichment than gene list B.   An example using microarray data, can is described in 
chapter 4 (tables 4 and 5) where biological replicates were used.   In both tables, superior 
enrichment was observed for gene lists generated using standard t-statistics when 
compared to fold change, although when using t-statistics, concordance between samples 
was inferior to fold change.  Another example was observed using flow cytometry data, 
where the gene list generated using SDI had a much higher GO enrichment than the gene 
list generated using average fold change, even though SDI samples had slightly lower 
concordance.   Based on these findings, we hypothesize that concordance is more suited 
to detect measurement or experimental variability rather than biological variability.  The 
fundamental idea behind this is that if biological differences exist between samples, we 
can always increase concordance by using a transformation which smooth’s the original 
data.  However, we should also keep in mind that by performing this type of smoothing 
transformation, we may also be losing valuable biological information.  This is the case 
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when extreme values in gene expression are biologically accurate, and smoothing the 
data will have the effect of down weighting these values, resulting in inferior GO 
enrichment. 
 
 
 
 
5.4 ASSOCIATION AND SAMPLE WEIGHT ESTIMATION 
Another concept of concordance is based on the idea that gene expression 
measurements in a sample are more reliable when the sample has a high reproducibility 
with respect to at least one of other remaining samples in a set.   In chapter 4, in addition 
to the previously described methods to estimate gene-specific variances, we also 
described some of the challenges of modeling sample-specific variances in unsupervised 
datasets by estimating sample weights.  To estimate sample weights two important 
concepts were used: linear association and concordance.     
 
5.4.1 Linear association between samples – CRAM model 
Sample weights were estimated using the CRAM algorithm, in which association 
between samples was identified.  To measure these associations, samples were regressed 
with remaining samples, generating a predicted log-intensity for every sample.  A sample 
weight is thus, a measure of association between observed and predicted log-intensity for 
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that sample.  In CRAM, the weight of a sample was estimated by applying a 
transformation such that the sum of square of the differences between predicted log-
intensity and transformed observed log-intensity was minimized.  This concept of 
estimating sample weights based on a linear regression was further extended to sub-
groups of genes within each sample.  A general framework was also presented assuming 
a known prior expected log-intensity for every gene. 
Results in heterogeneous datasets 1 and 2, showed that the WAME method, which 
has constant weights within each sample but different weights among samples and is 
supervised method similar to the basic version of CRAM, had significant improvement in 
GO enrichment when compared to fold change (which assumes all sample weights are 
equal).  This underlines the importance of modeling sample-specific variances as a way 
to detect more accurate biological patterns.   Moreover, when WAME was compared to 
CRAM, results in datasets 1, 3 and 4 showed CRAM with a marginal but significant 
improvement in GO enrichment, stressing the importance of modeling sample-specific 
variances within each sample, which is a main characteristic of the CRAM method.        
Estimating optimal sample weights is highly dependent on the dataset.  Our 
results show that sample weight estimation is highly dependent on the level of 
homogeneity between samples and will tend to perform better in homogeneous than in 
heterogeneous data.  The primary reason for this is that when large biological differences 
are present among samples, sample weights will usually be underestimated, since the 
CRAM model will interpret incorrectly that biological discrepancies among samples, are 
the result of noise (measurement error), rather than biological variability.  Nevertheless, 
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in practice, when CRAM was applied to heterogeneous datasets and datasets using 
biological replicates (homogeneous datasets), it generated superior GO enrichment to all 
other methods in datasets 1, 3 and 4, and was at least as good as WAME in dataset 2.   
Based on these findings, we hypothesize that CRAM is more accurate from a 
theoretical perspective, in experiments in which technical replicates are used, since 
biological replicates from homogeneous datasets can have high biological variability to 
the point that weights can be distorted just as in heterogeneous datasets.  Thus, in order to 
optimally model biological variability in both heterogeneous and homogeneous datasets, 
we developed CRAM-GS, which incorporates correlations between genes into the 
measure of differential expression.   
 
 
5.4.2 Concordance between samples – CRAM BINARY model 
  A robust version of CRAM (CRAM BINARY) was developed where 
concordance was used to estimate the weight of each sample.  Samples that had a high 
concordance with at least some other sample in the dataset were more heavily weighted 
whereas samples that had low concordance with all remaining samples were down 
weighted.  This use of concordance for weight estimation provides a robust measure of 
reproducibility between samples even when log-intensity values deviate largely from a 
Normal distribution.  Preliminary results comparing CRAM BINARY to fold change, 
generated superior GO enrichment in most cases. 
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5.5 LINEAR ASSOCIATION BETWEEN GENES 
Another novel model called CRAM gene correlation (CRAM-GC), was 
introduced in chapter 4, implementing an adjusted Spearman rank correlation between 
genes and improving on a recent work where gene correlations were modeled, but 
without any adjustment  (Leek and Storey 2008).  The main assumption is based on the 
fact that genes more highly correlated with other genes are likely to be enriched, 
compared to uncorrelated genes.  One of the main reasons for improvements in GO 
enrichment in CRAM-GC derives from the adjustment of rank correlations over all genes 
in order to correct for optimistic correlations.   
CRAM-GC when compared to fold change showed significant improvement in 
GO enrichment in both homogeneous and heterogeneous datasets, in one and two-
channel microarrays, and in paired and non-paired designs.   In CRAM-GC, rank 
correlation between genes was used as an extension of the concept of reproducibility, 
with the main advantage that any two genes do not need to be very similar in gene 
expression (log-intensity) in order to have a high association, and only need to have a 
high rank correlation.  Gene weights and sample weights were combined in the CRAM-
GC model, such that if a gene was not highly correlated with any other gene, the weight 
for that gene would be close to zero.  Thus, the expected fold change for that gene would 
be close to zero, resulting in the gene not being differentially expressed.  This down 
weighting of genes that had low correlation with all remaining genes is hypothesized as 
the main reason for the major improvement in GO enrichment.  We further hypothesize, 
that this improvement in GO enrichment, results from the fact that if a gene belongs to a 
particular GO category, then it is very likely to be highly correlated with at least another 
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gene in the same GO category.  This makes sense from a biological perspective, since a 
gene in the same GO category is very likely to belong to the same pathway of at least 
another gene in the same GO category, and thus is expected to have some level of 
statistical dependence, resulting in both genes being significantly correlated.  
 
 
5.6 CRAM: FUTURE WORK 
CRAM gene correlation (CRAM-GC) is the most powerful version of all the 
CRAM models, due to the high level of biological information obtained from 
incorporating gene correlations into the estimation of measures of differential expression.   
One potential improvement of CRAM-GC would be to group genes by GO category and 
perform gene-correlations restricted to genes within each GO category, generating a 
measure of differential expression for every gene and for every GO category.  This 
potential improvement of CRAM-GC would be feasible as long as GO categories have a 
reasonable size (≥ 20 genes).  This type of restriction by GO category, would generate 
much smaller gene correlation matrices, and would potentially increase biological 
accuracy by reducing the number the false positive genes resulted from high correlations 
between genes, which sometimes appear even after the adjustments based on Fisher’s 
transformation. 
The flexibility of CRAM models makes them highly applicable to some of the 
latest technologies in transcriptomics such as “Whole Transcriptome Shotgun 
Sequencing”, which aims at measuring RNA content (Morin, Bainbridge et al. 2008).   In 
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microarrays, CRAM models can also be easily adapted to one-channel datasets in which 
multiple probes are used for every gene.   Moreover, it can be also applied in flow 
cytometry datasets such as SDI measures.  Finally, CRAM can use prior knowledge for 
every gene, generated as outputs from similar experiments, together with the data from 
the current experiment in order to improve GO enrichment results. 
 
5.7 DETECTION OF HETEROGENEOUS CELL POPULATIONS –      
      SLOPE DIFFETENTIAL IDENTIFICATION (SDI) 
          In order to identify heterogeneous cell populations, we have described in  
chapter 3 the method Slope Differentiation Identification (SDI), which was shown to 
have superior performance in GO enrichment compared to other methods.  SDI also 
exhibits a high overlap with our gold standard gene list (gene lists obtained from 
stationary two peak distributions).   Validation via microscopy also indicated that SDI 
was superior in differentiating between quiescent (Q) and non-quiescent (NQ) cell 
populations in stationary phase cultures.  Moreover, SDI was shown to be highly 
computationally efficient taking only a few seconds to score the whole Green 
fluorescence protein (GFP) dataset. 
           
5.7.1 Multi-dimensional fold change 
         SDI is an extension of the concept of fold change in log-fluorescence intensity 
between two conditions, in a sense that it is applied to multiple dimensions.   In the flow 
experiment described in chapter 3, SDI had two additional dimensions besides 
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fluorescence intensity: side-scatter and forward-scatter.  These two additional dimensions 
were used as control variables, where averages of fold change of log-fluorescence 
intensity were evaluated for different levels of side-scatter and forward-scatter.    
Although recent studies have used clustering methods to model multi-dimensional 
flow datasets, these are not optimized to model differences between two conditions in 
multiple dimensions (Zeng, Pratt et al. 2007; Pedreira, Costa et al. 2008).  The modeling 
of the differences in log-fluorescence intensity between stationary and exponential phase 
cultures, controlled either by side-scatter or forward-scatter, was shown to add 
discriminatory power in accurately detecting heterogeneous cell populations.   One of the 
advantages in modeling the differences in log-fluorescence intensity between two 
conditions rather than modeling each condition separately is that differences in log-
intensity provide a highly simplified model for every GFP-fusion strain.  Another reason 
in modeling differences in fluorescence intensity comes from the strong association 
between conditions, for a given GFP-strain, and therefore noise levels of the predicted 
values from the model, are largely reduced.  This same procedure can be extended to 
more dimensions, in which case, each dimension would be used as a control variable 
whereas the differences in log-fluorescence intensity would be the dependent (or 
explanatory) variable.   
 
5.7.2 Modeling SDI using multi-dimensional flow data 
    Defining the correct binning of a control variable is a crucial step for modeling 
multi-dimensional differences in log-fluorescence intensity.  Although the fluorescence 
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intensity is measured for every cell (event), differences in log-fluorescence intensity can 
only be measured for a group of events.  In this case, groups are defined based on 
different ranges of a control variable (side-scatter or forward-scatter in our experiment).  
This grouping procedure may be applied simultaneously to a set of multiple control 
variables and their respective ranges, where the average of the difference in log-
fluorescence intensity between two conditions is estimated for each group. 
        An improvement of SDI to handle multi-dimensional data would be to generate a 
regression tree for every GFP, combining the most important control variables in which 
branches and nodes would be selected based on the most significant differences in 
average log-fluorescence intensity between two conditions.  The output of such trees for 
every GFP would produce nodes with various levels in differences in log-intensity (fold 
change), where large variations in fold change between nodes, such as high average fold 
change for some nodes and low average fold change for other nodes, which would be 
indicative of the presence of heterogeneous cell populations. 
 
5.7.3 Modeling SDI with multiple conditions 
 In chapter 3 it was shown that the pairing between stationary and exponential 
phase was necessary in order to calculate the differences in log-fluorescence intensity, 
controlled by either side-scatter or forward-scatter.  This pairing requirement is essential 
when testing for multiple conditions, where fold change between each pair of conditions 
is modeled.  This approach may be applied to time course experiment in which every two 
consecutive time points are treated as two different conditions.  Moreover, we can extend 
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the concept of differences between two time points using experimental design contrasts in 
which three or more time points are used.  This would allow h 
igher order differences to be calculated, such as acceleration in fold change. 
 
 
 
5.7.4 Limitations of concordance between samples 
 Although concordance between samples in a dataset is a strong indicator of 
confidence in data reproducibility, it is not always an indication of optimal enrichment.  
For example, in the flow dataset, average fold change had an average concordance 
between samples equal to 73% vs. 63% for SDI, whereas the enrichment for SDI was 
clearly superior to average fold change.  As an example, the overlap between AFC list 
and the gold standard stationary SPV list was only 31% (46/147), whereas the overlap 
between SDI list and SPV list was 65% (96/147).   Recent studies suggest that in order 
for biological knowledge to be inferred from the data it is necessary that we have 
reproducible samples (Shi, Perkins et al. 2008).  However, as our examples show, having 
optimal reproducibility between samples does not imply that the approach is optimal to 
detect the main biological relationships we are interested in, which was also the case for 
SDI.  Therefore, the most accurate statistical approaches are likely to have both: highly 
reproducible samples and significant GO enrichment. 
 With the large increase in the amounts of data generated from recent technologies 
such as flow cytometry, we expect that future improvements in SDI will be suited for 
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disease studies such as Cancer, and to better understand important biological relations, 
which result from identifying heterogeneous cell populations.  In addition, we expect that 
further development of the CRAM methodology, will combine datasets from similar 
experiments to generate more biological accuracy.  Finally, given the increase in number 
of dimensions in flow data (approximately 30 dimensions in the next few years) and 
further improvement in gene annotations to GO categories, we believe there is a huge 
potential for developing methods that optimally model biological relations.   
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